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CHAPTER I
Introduction
The United States has the most expensive healthcare system in the world with
healthcare spending reaching $3.0 trillion or $9,523 per person in 2014 (Centers for
Medicare & Medicaid Services 2014). However, reports consistently demonstrate that
the U.S. underperforms on most dimensions of healthcare performance compared to
other countries. Two critical challenges facing healthcare providers, and more broadly
society, are controlling the cost of providing care to patients and improving the qual-
ity of the outcomes. This dissertation addresses these challenges at the patient level
by developing stochastic control and optimization methods to better personalize the
medical care and the delivery of care. The main unifying theme of this dissertation
is the unprecedented use of data/information to design innovative decision support
tools that keep the focus of care on the patients, their experience, and their outcomes
and reduction of wasted resources. In other words, we leverage operations research
techniques to develop patient-centered optimization models and decision methods to
improve the quality of care, patient safety, and timeliness of access to care at lower
cost, which all will result in better patient outcomes and therefore, a healthier society.
This dissertation is presented in a multiple manuscript format. The results in Chap-
ters II, III and IV have appeared as individual research papers Kazemian et al.
(2016a), Kazemian et al. (2014), and Kazemian et al. (2016b).
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In Chapter II, we take a step toward improving the quality of care and cost con-
tainment by integrating and personalizing the monitoring and treatment of chronic
diseases. Chronic diseases affect almost one out of every two adults (Ward et al.
2014) and the treatment of them accounts for the expenditure of over 75% of direct
healthcare costs in the U.S. (Thrall 2005). To effectively manage chronic disease pa-
tients, clinicians must know (1) how to monitor each patient, and (2) how to control
the disease. In the treatment of chronic diseases, patients are quantitatively tested
at prescribed intervals to monitor the degree of disease progression and subsequently
whether a change in treatment is warranted. Hence, there are decisions on which
tests to take and when to take them, as well as what treatments/interventions are
needed. Tests are associated with costs to account for side-effects, discomfort, and
inconvenience as well as the monetary cost of the test itself. Chapter II presents a
dynamic personalized modeling framework that enables clinicians to (1) specify the
optimal timing of each office visit and the appropriate subset of tests to perform
at that visit considering the costs and value of each test and the uncertainty about
the patient’s disease state so as to achieve an accurate perception of disease progres-
sion without burdening patients and the healthcare system with over-testing [disease
monitoring], and (2) identify optimal target levels for controllable disease risk factors
to slow the rate of disease progression to an acceptable level without over-treating
or under-treating the patient [treatment control]. We do so by providing the jointly
optimal solution to a novel linear quadratic Gaussian state space model. For the new
objective of minimizing the relative change in state over time (i.e., disease progres-
sion), which is necessary for management of irreversible chronic diseases, we show that
the classical two-way separation of estimation and control holds, thereby making a
previously intractable problem solvable by decomposition into two separate, tractable
problems while maintaining optimality. The resulting optimization is applied to the
management of glaucoma. Based on data from two large randomized clinical trials,
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we validate our model and demonstrate how our decision support tool can provide
actionable insights to the clinician caring for a patient with glaucoma. This method-
ology can be applied to a broad range of irreversible chronic diseases to optimally
devise patient-specific monitoring and treatment plans. It can assist in managing the
tradeoff between maximizing information about the disease and its control and the
amount of healthcare resources (e.g., office visits and tests) to be provided. Further,
this approach can broaden the quality of care to more people because it elevates the
care even when provided by non-experts (e.g., optometrists and general ophthalmol-
ogists taking care of glaucoma patients). Therefore, the statistical and optimization
framework developed in this work has the potential for broad impact on longitudinal
patient care as well as cost containment.
Chapter III focuses on improving patient safety and therefore, improving health out-
comes. This research was motivated by the new Accreditation Council for Graduate
Medical Education (ACGME) duty-hour standards for residents and fellows that went
into effect in 2011. These regulations were designed to reduce fatigue-related medical
errors and improve patient safety. The new shift restrictions, however, have led to
more frequent transitions in patient care (handoffs), resulting in greater opportunity
for communication breakdowns between caregivers, which correlate with medical er-
rors and adverse events. Recent research has focused on improving the quality of these
transitions through standardization of the handoff protocols; however, no attention
has been given to reducing the number of transitions in patient care. Chapter III
leverages integer programming methods to design a work shift schedule for trainees
that minimizes the number of error-prone patient handoffs which will result in fewer
medical errors due to communication breakdowns. The new schedule complies with
all ACGME duty-hour standards, provides required coverage, and maintains physi-
cian quality of life. We add constraints on physician’s sleep hours, circadian rhythm
and other human factors issues to reduce the fatigue-related medical errors and fur-
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ther improve the patient safety. Moreover, this approach can reduce healthcare costs
by optimizing the number of providers required. In a case study of redesigning the
trainees’ schedule for a Mayo Clinic Intensive Care Unit (ICU), we show that the
number of patient handoffs can be reduced by 23% and still meet all required and
most desired scheduling constraints. Furthermore, a 48% reduction in handoffs could
be achieved if only the minimum required rules are satisfied.
Chapter IV addresses timely access to care and coordinated care delivery. Providing
timely access to surgery is crucial for patients with high acuity diseases like can-
cer. In Chapter IV, we present a methodological framework to make efficient use of
scarce resources including surgeons, operating rooms, and clinic time slots to meet
the access delay service level for elective surgery using colorectal surgery (CRS) at
the Mayo Clinic as a case study. We personalize the system to offer different tiers
of access based on the acuity of patient’s disease so that the more urgent cases are
treated more promptly. Further, we increase the level of performance of the system
to reduce waste of precious operating room time. In this chapter, we propose and
evaluate 6 heuristic scheduling policies. All policies dramatically outperform the cur-
rent scheduling protocol. The underlying idea behind these scheduling policies is the
efficient and innovative use of patient information to tentatively book a surgery day
at the same time the clinic appointment is set. We develop a logistic regression model
to calculate for each clinic appointment order the probability that it will result in a
surgery in CRS. Then, we creatively space out the clinic and surgery appointments
such that if the patient does not need his/her surgery appointment, we have enough
time to offer that to another patient. We develop a 2-stage stochastic and dynamic
discrete-event simulation model to evaluate the 6 scheduling policies. In the first stage
of the simulation, these policies are compared in terms of the average operating room
overtime per day. The second stage involves fine-tuning the winning policy. This
methodology is applied to historical patient data from Mayo CRS. Numerical results
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Table 1.1: Overview of the dissertation topics and their main contributions.
demonstrate that the optimal policy performs 52% better than the current schedul-
ing policy. Table 1.1 outlines the three main research topics of this dissertation and
enumerates the main contributions of each chapter.
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CHAPTER II
Dynamic Monitoring and Control of Irreversible
Chronic Diseases with Application to Glaucoma
2.1 Introduction
Chronic diseases are the leading cause of death and disability and affect almost one
out of every two adults in the United States (Ward et al., 2014). In the management
of chronic diseases, patients are quantitatively tested at prescribed intervals using a
selected set of testing modalities to assess disease progression and decide whether a
change in treatment is warranted. In this context, proper testing and treatment guid-
ance is critical to both cost containment and patient outcomes in the management
of chronic disease. In this chapter we develop a modeling framework for dynamic
management of irreversible chronic diseases that enables us to (1) specify the optimal
timing of each office visit and the appropriate suite of tests (i.e., the selection of test-
ing modalities) to perform at that visit considering the costs and value of each test
and the uncertainty about the patient’s disease progression [disease monitoring], and
(2) identify optimal target levels for controllable disease risk factors to slow the rate
of disease progression without over-treating or under-treating the patient [treatment
control].
To do so, we introduce and solve a new type of objective function for linear quadratic
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Gaussian (LQG) systems that minimizes the relative change in state (i.e., disease
progression) rather than the traditional objective of minimizing the cost of being
in each state. We extend LQG theory by proving for this new objective that the
classical two-way separation of optimal state estimation and control applies. This
separation ensures computational tractability for the simultaneous optimization of
disease monitoring and treatment control. This innovative modeling of dynamic dis-
ease monitoring and treatment control is developed generally to be applicable to many
irreversible chronic diseases. As a proof of concept, we demonstrate the capabilities
of this methodology by applying it to glaucoma, a chronic disease causing progressive
blindness.
2.1.1 Scope of the Research
It is important to distinguish the disease monitoring problem from screening for
a disease. The goal of disease screening is to determine whether or not a patient has
a particular disease. A screening test is taken when the patient is considered to be
at some risk of developing a condition but exhibits no symptoms of the illness. In
contrast, for the disease monitoring problem the patient is already known to have
the disease and the goal is to quickly detect the presence of disease progression and
identify whether/how to adjust the treatment plan to slow/avert further disease pro-
gression.
For the treatment control portion of the problem, the goal is to determine the time-
dependent intensity of treatment over a treatment cycle based on dynamically updat-
ing information on patient disease state from the monitoring portion. We emphasize
that our model does not suggest a specific intervention. Rather, it provides patient-
specific target levels for controllable/modifiable disease risk factors that help guide
the doctor in selecting an appropriate treatment plan for the patient. Though one
might try to model how each intervention affects the disease progression dynamics,
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we feel it best to leave it to the clinician to employ his/her experience and expertise
to decide what therapeutic interventions are most likely able to achieve the target
levels suggested by our model.
2.1.2 Main Contributions
• Theoretical: (1) To the best of our knowledge, this is the first research to em-
ploy measurement adaptive systems theory to monitoring and control of chronic
diseases (or even to any healthcare operations research problem), and this new
application requires a major extension of the underlying theory. We extend
the LQG state space modeling literature by introducing a new objective that
minimizes the relative change in system state over time (i.e., the difference in
estimated state elements between the current period and the previous period),
rather than minimizing the cost of current state. In the previous literature, the
goal of the controller has been to keep the system state on a static desired tra-
jectory using costly control actions by minimizing the deviation of the current
system position from the desired trajectory. However, in irreversible diseases
such as glaucoma, once the disease has progressed, it is biologically impossible
to recover the damage. In the context, the desired trajectory is to maintain the
“current disease state position” (i.e. stop the disease from worsening), which
the model dynamically updates as the disease progresses over time. This neces-
sitates a new structure for the objective function (Eq. 2.3) not yet studied in
LQG literature.
(2) For LQG systems theory, the two-way separation of optimal state estimation
and control (known as the separation principle) has been a critical foundation
upon which to tractably and simultaneously optimize estimation and control
of probabilistic systems (see Witsenhausen 1971). Our main theoretical results
show that the two-way separation of optimal estimation and control extends
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to this new objective of relative system state change, which involves two cor-
related state variables from the current and previous time periods. The treat-
ment control can be optimized in closed form as a linear function of the best
estimate of the patient’s current disease state (i.e., filtered state mean given
by the Kalman filter) via completion of squares. Furthermore, we show that
the monitoring problem can be reduced to a continuous-state discrete-action
Markov decision process (MDP) model with filtered and smoothed covariance
matrices of the state serving as the information state and the Kalman filter and
smoother equations acting as the system dynamics. The MDP can be solved
via branch-and-bound dynamic programming to find the optimal monitoring
schedule specific to each individual patient.
(3) Kalman filter and smoother are built into our modeling framework to ex-
tract noise from the raw measurements and to optimally estimate the disease
state in each time period based on imperfect/noisy measurements. This is a
key to accurately identifying genuine disease progression from testing artifacts.
Kalman smoother is a new feature in our model (compared with the traditional
LQG models), which is essential because of the new objective function we em-
ploy. State smoothing means using information gained at time t to update the
prior estimate made at t− 1 of the value of the state at t− 1; filtering refers to
estimating the current disease state based on new test results.
• Practical: (1) We develop an integrated, feedback-driven stochastic control
model to provide the jointly optimal solution to both the disease monitoring
and treatment control problems. It is worth noting that the disease control prob-
lem is affected by the monitoring regime because as new tests are performed,
more information about the patient’s disease state and disease dynamics be-
come available. Such information can affect how the doctor controls/slows the
progression of the disease. Therefore, it is critical to model and solve the disease
9
monitoring and control problems together to capture the interaction between
them.
(2) The model explicitly determines which suite of tests to take at each time
period. Some tests are significantly easier and cheaper to do than others. Dif-
ferent tests may provide less or more information about the patient’s disease
state. Therefore, it is important to be able to differentiate which tests to do at
each time point in terms of improved monitoring and cost containment.
(3) We develop a data-driven decision support tool that provides a menu of
options to the doctor based on how aggressively he/she wants to monitor and
control the patient. The doctor can select an appropriate aggressiveness op-
tion depending on the patient’s life expectancy, severity of disease, and other
personal and clinical factors. For each aggressiveness option, the model incor-
porates new and past test results as well as clinically-believed and data-verified
disease dynamics to predict and graph the future disease trajectory and rec-
ommend a patient specific monitoring regime and target level for controllable
disease risk factors.
• Data: (1) We parametrize and validate our model using data from two land-
mark randomized clinical trials of patients with glaucoma. Our numerical re-
sults confirm that the model demonstrates low error in predicting the future
disease trajectory.
(2) Our model demonstrates potential for improving both patient outcomes and
system cost when applied to patients from the clinical trial, which are already
receiving a high level of care. This potential is likely greater for patients being
treated by non-glaucoma specialists.
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2.2 Literature Review
Papers relevant to this research are classified into three categories: (1) theoretical
papers on measurement adaptive systems and sensor scheduling, (2) medical decision
making papers on disease screening, diagnosis, and monitoring, and (3) optimization
models on treatment planning and disease control. In this section we highlight some
prominent papers in each category and briefly describe how our research methodolo-
gies and objectives are different.
Measurement Adaptive Systems and Sensor Scheduling: The closest paper
to our work in terms of theory is Meier et al. (1967). This paper lays the foun-
dations for measurement adaptive systems in which the controller tries to keep the
system state on a static desired trajectory and simultaneously obtain information
about the system state with minimum total cost over a finite horizon. They show
that in the special case of discrete-time systems, linear system dynamics, quadratic
cost of the current state, and Gaussian random noise processes, the problem of finding
the optimal measurement policy reduces to the solution of a nonlinear, deterministic
control problem. Baron and Kleinman (1969) extend their work to continuous-time
measurements and investigate the optimal measurement duration for a human op-
erator. Bansal and Bas¸ar (1989) provide an extension of this framework to the
infinite-horizon setting with discounted costs. Our work differs in that it deals with a
dynamic desired trajectory, minimizing the relative change in state in each time pe-
riod (i.e., disease progression), which is essential for the management of irreversible
chronic diseases as discussed in Subsection 2.1.2. For example, experiments using the
model provided by Meier et al. (1967) lead to results that were considered clinically
incorrect/unbelievable in the experience of our clinical co-author, a glaucoma special-
ist.
There is also extensive literature on sensor scheduling problems, in which a set of
sensors is used to estimate a stochastic process, but because of cost or design con-
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straints only one or a subset of them takes measurements at each time point. Athans
(1972) considers the problem in which the controller has to select, at each time step,
one measurement provided by one sensor out of many available sensors (with dif-
ferent measurement costs), such that a weighted combination of prediction accuracy
and accumulated observation cost is minimized. Examples of other work in this area
include Gupta et al. (2006), Mehra (1976), and Vitus et al. (2012). However, these
papers differ from ours in that they do not consider the tradeoff between exploration
vs. exploitation.
Disease Screening, Diagnosis, and Monitoring: While there is an extensive lit-
erature on disease screening and diagnosis problems, there is relatively little work on
the disease monitoring problem that we defined in Section 2.1.1. Helm et al. (2015)
and Schell et al. (2014) provide a heuristic approach for finding the time to next test
based on patient’s probability of progression. Ayer et al. (2012) provide a partially ob-
servable Markov decision process (POMDP) approach to personalize mammography
screening decisions based on the prior screening history and personal risk character-
istics of women. Chhatwal et al. (2010) develop a finite-horizon discrete-time Markov
decision process (MDP) model to help radiologists determine the best time for biopsy
based on the initial mammography findings and patient demographics to maximize a
patient’s total expected quality-adjusted life years. The works of Yang et al. (2013),
Mangasarian et al. (1995), and Saaty and Vargas (1998) are other examples of dis-
ease screening models. These works differ from ours in that they focus on screening
problem where the goal is to detect the presence of a particular disease with minimum
delay. They do not provide any insights on how to monitor the patient if the presence
of the disease is confirmed and progression trajectory can be monitored over time;
nor do they consider treatment planning.
Treatment Planning and Disease Control: There has been a variety of works
considering when to start treatment of a patient when the presence of disease is con-
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firmed (also known as surveillance problems). Lavieri et al. (2012) develop a Kalman
filter-based approach to help clinicians decide when to start radiation therapy in
patients with prostate cancer based on predictions of the time when the patient’s
prostate specific antigen (PSA) level reaches its lowest point. Shechter et al. (2008)
employ Markov decision processes (MDP) to optimize the time to initiate HIV treat-
ment to maximize quality-adjusted life years of a patient. Mason et al. (2014) present
an MDP model to determine the optimal timing of blood pressure and cholesterol
medications. All of these works assume a measurement of the patient’s health is
taken periodically. Our work differs in that it solves the joint problem of optimal
timing of each test and optimal treatment control.
Moreover, in most of the previous research mentioned, the patient’s disease dynamics
are assumed to be known or are estimated from population-based models. In our
model, the population data is integrated with individual patient measurements that
are gathered from sequential testing so that the predictions and decisions made are
unique to each patient. Capturing the complex patient disease dynamics requires
incorporating several health indices into the state vector. We employ a continuous
state space that easily accommodates multivariate states (e.g. 9 dimensions in our
model for glaucoma) and provide the jointly optimal solutions to both disease moni-
toring and control problems. Employing a continuous state space model is important
as many quantitative tests for disease monitoring are in continuum. Problems with
such a multivariate, continuous state-space often become intractable for MDP-based
approaches due to the curse of dimensionality. Discretization of the state space and
using approximate dynamic programming (ADP) to mitigate the curse of dimension-
ality of MDP models is an alternative approach when our modeling framework does
not fit. For example, strongly discrete state variables, highly non-linear disease dy-
namics, and highly non-Gaussian random noises are features that are difficult for our
model to handle.
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2.3 The Modeling Framework
A continuous state space model is employed at the heart of our modeling frame-
work with two key components: (1) a state transition process to model disease pro-
gression dynamics, and (2) a measurement/testing process to model how the true
disease state is observed. Both processes (Eq.’s 2.1 and 2.2) are in the form of first
order vector difference equations with additive Gaussian white noise (i.e., noise inputs
at time t and t′ are independent).
2.3.1 State Transition Process
The recursive state transition equation for our N-stage time horizon is given by
αt+1 = Ttαt +Gtβt + ηt, t = 1, ..., N, (2.1)
where αt is the random variable representing the state of the disease at time t, βt
is the “disease control” variable administered at time t, ηt is the vector of Gaussian
white noise that represents unmodeled disease process noise with E [ηt] = 0 and
V ar (ηt) = Qt, Tt is the state transition matrix governing the underlying disease
progression dynamics and Gt is a vector capturing the effect of disease control variable
βt on the next period state, αt+1. βt is one of the two optimization variables of the
model. It determines how the modifiable disease risk factors should be adjusted at
time t to optimally slow the progression of disease. Having such information will help
clinicians select the appropriate treatment plan for the patient.
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2.3.2 Measurement/Testing Process
The measurement equation gives the relationship between the true disease state,
αt, and the noisy raw reading/observation, zt, as follows.
zt = Ztαt + εt, t = 1, ..., N, (2.2)
where zt is the observation vector (i.e., the result of test(s) performed on the pa-
tient), Zt is the observation matrix and determines how components of the true state
are observed, εt is the multi-variate Gaussian white test noise with E [εt] = 0 and
V ar (εt) = H
(θt)
t . θt is the “test/measurement control” variable that determines which
subset of tests to take in period t and is the other control variable the model opti-
mizes. H
(θt)
t models the error associated with the tests and is directly affected by the
decision on which test(s) to take at time t (which we highlight by adding (θt) to the
superscript, i.e., H
(θt)
t ). It is worth noting that both αt+1 and zt are Gaussian random
vectors since they are a linear combination of independent Gaussian random variables.
The initial state, α0, is Gaussian with E [α0] = αˆ0 = αˆ1|0 and V ar (α0) = Σˆ0 = Σˆ1|0.
The random variables α0, {ηt}, and {εt} are mutually independent. Throughout the
chapter, the notation Xˆt|t′ means the estimated value of random variable X at time
t with information up to time t′.
2.3.3 Objective Function
The novel objective function (performance criterion) we analyze is given by
J = E
{
N∑
t=1
[
(αt − αt−1)′At (αt − αt−1) + βt′Btβt + lt(θt)
]
+ (αN+1 − αN)′AN+1 (αN+1 − αN)
}
,
(2.3)
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in which At is the unit cost matrix of further worsening of the disease, Bt is the unit
cost of administering disease control (i.e., further adjusting the modifiable disease
risk factor), and the scalar lt(θt) is the cost of taking tests/measurements in period
t, which depends on the test control variable, θt.
The objective function consists of four terms: (1) (αt − αt−1)′At (αt − αt−1) is the
cost of relative change in the system state random variable (i.e., disease progression)
between the previous period t − 1 and the current period t (whereas the traditional
LQG objective minimizes αt
′Atαt as explained in Subsection 2.1.2), (2) βt
′Btβt is the
cost of controlling the disease risk factors including side effects and complications of
medical or surgical treatments, (3) lt(θt) is the cost of undergoing additional testing,
and (4) (αN+1 − αN)′AN+1 (αN+1 − αN) is the terminal cost of relative state change
at the end of the treatment horizon. The quadratic form of the first part of the ob-
jective function ensures that a large disease worsening is penalized more aggressively
than a small one. Furthermore, achieving a large adjustment in disease risk factors
may require more aggressive treatments (e.g. surgery or laser therapy), which are
associated with higher monetary costs and more side effects and discomfort than a
smaller change in risk factors, which can often be achieved by simpler treatments like
medications. Hence, the cost associated with a big relative change in patient’s disease
risk factors is much higher than a small one, and so the quadratic form of the second
part of the objective function is a good choice for our application.
2.3.4 Kalman Filter and Kalman Smoother
When the state transition and measurement processes are both in the form of first
order difference equations with Gaussian white noises, the optimal state estimation
(to minimize the mean squared error of the estimate) is given by the Kalman filter
(Kalman 1960). The Kalman filter obtains the prediction of state mean and covari-
ance at time t with information up to time t−1, αˆt|t−1 and Σˆt|t−1 respectively, and the
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current reading, zt, as inputs to the algorithm and calculates the filtered state (i.e.,
optimal estimate of the true state) mean and covariance, αˆt|t and Σˆt|t respectively.
The optimal state mean estimate at time t with information up to time t, αˆt|t, is given
by
αˆt|t = αˆt|t−1 +Kty˜t, (2.4)
where αˆt|t−1 is the predicted state mean at time t given information up to time t− 1
and y˜t is the measurement residual (error) given by
αˆt|t−1 = Tt−1αˆt−1|t−1 +Gt−1βt−1, (2.5)
y˜t = zt − Zt(Tt−1αˆt−1|t−1 +Gt−1βt−1), (2.6)
and Kt is the Kalman gain given by
Kt = Σˆt|t−1Zt′S−1t , (2.7)
in which St is the predicted covariance around the measurement given by ZtΣˆt|t−1Zt′+
H
(θt)
t .
The predicted state covariance at time t given the information up to time t−1, Σˆt|t−1,
and the most recent state covariance estimate at time t with information up to time
t, Σˆt|t, satisfy
Σˆt|t = Σˆt|t−1 − Σˆt|t−1Zt′
(
ZtΣˆt|t−1Zt′ +H
(θt)
t
)−1
ZtΣˆt|t−1 = (I −KtZt) Σˆt|t−1, (2.8)
Σˆt|t−1 = Tt−1Σˆt−1|t−1Tt−1′ +Qt−1. (2.9)
The initial state mean and covariance, αˆ1|0 and Σˆ1|0 respectively, are calculated based
on population data from clinical trials. For more discussion on Kalman filter please
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see Bertsekas et al. (1995) and Harvey (1990).
Because of the special form of the objective function that minimizes relative state
change from time t − 1 to time t (i.e., disease progression) we need to refine the
estimation of previous state mean and covariance after a new measurement is taken
at time t (αˆt−1|t and Σˆt−1|t respectively). This is called state smoothing and can be
done via fixed-interval Kalman smoother as follows.
αˆt−1|t = αˆt−1|t−1 + Σˆ∗t−1
(
αˆt|t − αˆt|t−1
)
, (2.10)
Σˆt−1|t = Σˆt−1|t−1 + Σˆ∗t−1
(
Σˆt|t − Σˆt|t−1
)
Σˆ∗t−1
′, (2.11)
in which Σˆ∗t−1 = Σˆt−1|t−1Tt−1
′Σˆ−1t|t−1. A derivation of the fixed-interval Kalman smooth-
ing can be found in Ansley and Kohn (1982).
The control system block diagram is depicted in Figure 2.1. The dashed arrows in-
dicate that the information is carried over from the current period, t, to the next
period, t + 1. The values in parentheses are not observable. Suppose the patient
is in disease state αt when visiting the doctor’s office. Based on the optimal test
control action θ∗t (already determined in the previous time period), all or a subset of
tests are performed on the patient. The noisy observation/reading, zt, is then sent to
the Kalman Filter. Based on the predicted and observed states, the Kalman Filter
algorithm calculates the best estimate of the mean and covariance of the patient’s
disease state in period t, αˆt|t and Σˆt|t respectively, and sends the filtered values to
both the Kalman Smoother and the controller (i.e. the decision support system itself
for this analysis). The Kalman Smoother will then modify the best estimates of the
state mean and covariance in period t − 1, αˆt−1|t and Σˆt−1|t respectively, and send
the smoothed values to the controller. Notice that this is a key departure from the
traditional methodology. The controller receives both the filtered and smoothed val-
ues of the patient’s disease state mean and covariance (the information state for the
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optimization component of the model) and outputs the optimal treatment and test
control actions, β∗t and θ
∗
t+1. Finally, the prediction of the state mean and covariance
in period t+ 1, αˆt+1|t and Σˆt+1|t, is sent to the Kalman filter and smoother to be used
in the following time period.
In Section 2.4, we focus on the controller (decision support tool) and show how the
optimal disease and test control actions (β∗t and θ
∗
t+1, respectively) can be calculated
given the information state ℘t =
(
αˆt|t, Σˆt|t, αˆt−1|t, Σˆt−1|t
)
.
Figure 2.1: Control system block diagram.
2.3.5 Separation of Estimation and Control
One-way Separation of Estimation and Control: A control law is a function
selected by the controller from the set of all admissible functions based on all data
available at the time of the decision. This function generates a control action to be
applied to the system. The problem is to make an optimal selection of such functions
for all time steps that achieves the minimum expected cost (defined by the objective
function) for the control horizon of the problem. For the general stochastic control
problem with imperfect observations, given all the observations and previous control
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actions, state estimation from noisy data is always independent of the control law.
This is because the conditional density of the state given all the observations and the
control actions is independent of the control law. This result is called the separation
principle in control theory (see Witsenhausen 1971). The only underlying assumption
for the separation principle to hold is to have one controller (i.e., centralized infor-
mation) with perfect recall (i.e., the information on the previous observations and
control actions do not get lost).
In general, the control law depends on the estimation of the system state; but, the
estimation at time t is independent of all control laws given all observations up to
time t and all the control actions up to time t− 1. This is also known as the one-way
separation of estimation and control. Since our LQG model is a special case of the
general stochastic control problem with centralized information and perfect recall,
the one-way separation principle holds. As seen in Section 2.3.4, the optimal state
estimation at time t, described by αˆt|t and Σˆt|t, is given by the Kalman filter (Eq.’s
2.4-2.9) and is independent of the control law given all the previous observations and
control actions.
Two-way Separation of Estimation and Control: For LQG stochastic systems
in which (1) the transition and measurement equations are linear in state and control
action, (2) the objective function penalizes the quadratic cost of current state, and
(3) the state and measurement noises are Gaussian, it has been shown that the con-
trol law is also independent of the state estimation (Meier et al. 1967). Therefore, for
this traditional form of LQG models we have two-way separation of the estimation
and the control; namely, the estimation is independent of the control law and the
control law is independent of the estimation. In Section 2.4, we show for the new ob-
jective of minimizing the relative change in state, which involves two correlated state
variables of current and previous time periods and requires smoothing in addition to
filtering and prediction, that the optimal control law is still independent of state es-
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timation. Thus, in this new and more complex environment, the two-way separation
still holds. Furthermore, the optimal control action is linear in state estimation. This
is extremely desirable for application because the control law is data independent
and can be calculated offline (which greatly reduces the computational burden). The
two-way separation of estimation and control for this special case of LQG models is
a fundamental finding, which is critical to solution tractability.
2.4 Derivation of Optimal Disease and Test Controls
In this section we derive the optimal disease and test control actions given the in-
formation state at time t, ℘t, which is defined as the filtered state mean and covariance
at time t with information up to time t and the smoothed state mean and covariance
at time t− 1 with information up to time t, i.e. ℘t =
(
αˆt|t, Σˆt|t, αˆt−1|t, Σˆt−1|t
)
.
In terms of ℘t, a dynamic programming algorithm can be derived to find the opti-
mum disease and test controls. The value function, Vt (℘t), can be found recursively
as follows.
Vt (℘t) = min
βt,θt+1
{
Lt(℘t, βt, θt+1) + E
zt+1
[Vt+1 (℘t+1)]
}
, t = 1, . . . , N − 1, (2.12)
where Vt (℘t) is the minimum expected cost from period t to N , the end of the
control horizon, given the information state ℘t, and Lt(℘t, βt, θt+1) is the expected
instantaneous cost incurred in period t if the information state is ℘t and the control
actions βt and θt+1 are chosen, given by
Lt(℘t, βt, θt+1) = E
[
(αt − αt−1)′At (αt − αt−1)
]
+ β′tBtβt + lt+1(θt+1). (2.13)
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The boundary condition is given by
VN (℘N) = min
βN
{
L˜N(℘N , βN)
}
, (2.14)
where L˜N(℘N , βN) is the expected cost incurred in the final period N if the informa-
tion state is ℘N and the disease control action βN is chosen.
The minimum cost during the entire control horizon can, therefore, be obtained by
J∗ = l1(θ1) + V1(℘1), (2.15)
in which l1(θ1) is the cost of initial tests during the patient’s first office visit and
V1(℘1) is the minimum cost to go from period 1 to the end of control horizon obtained
recursively via Eq.’s 2.12 and 2.14. We assume all diagnostic tests are taken at the
first visit.
In the remainder of this section we use an induction argument to prove the following
theorems.
Theorem II.1. For arbitrary time t (t = 1, . . . , N), the control law is independent
of the state estimation (i.e., we have two-way separation of optimal estimation and
control). Moreover, the optimal disease control, β∗t , is linear in the filtered state mean,
αˆt|t.
Theorem II.2. At an arbitrary time t (t = 1, . . . , N), the optimal monitoring sched-
ule, θ∗t+1, θ
∗
t+2, . . ., can be found by solving a continuous-state discrete-action MDP
model with filtered and smoothed covariance matrices of the state serving as the in-
formation state and the Kalman filter and smoother equations acting as the system
dynamics.
Theorem II.3. For arbitrary time t (t = 1, . . . , N), the value function with infor-
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mation up to time t has the following form.
Vt (℘t) =
(
αˆt|t − αˆt−1|t
)′
At
(
αˆt|t − αˆt−1|t
)
+ tr
[
AtΣˆt|t
]
+ αˆ′t|tPtαˆt|t + tr
[
PtΣˆt|t
]
+ V θt
(
℘θt
)
+ bt, (2.16)
in which V θt
(
℘θt
)
represents the recursive terms that only depend on measurement
control actions, i.e., when to take tests and which test(s) to take. They do not depend
on the observations or on the disease control actions. Therefore, the measurement
control problem can be solved separately from the treatment control problem. ℘θt rep-
resents those elements of information state that are only affected by measurement
control actions (i.e., ℘θt =
(
Σˆt|t, Σˆt−1|t
)
), and bt is a constant. V
θ
t
(
℘θt
)
and bt will be
obtained later in the proof.
Proof by induction: In Appendix 2.7.1 we prove that the value function in the
final period is given by
VN (℘N) =
(
αˆN |N − αˆN−1|N
)′
AN
(
αˆN |N − αˆN−1|N
)
+ tr
[
AN ΣˆN |N
]
+ αˆ′N |NPN αˆN |N + tr
[
PN ΣˆN |N
]
+ tr
[
AN
(
ΣˆN−1|N − TN−1ΣˆN−1|N − ΣˆN−1|NTN−1′
)]
+ tr
[
P˜N+1ΣˆN |N
]
+ tr [AN+1QN ] , (2.17)
where tr represents the trace of the matrix. By comparing Eq.’s 2.16 and 2.17 we see
that (induction basis)
V θN
(
℘θN
)
= tr
[
AN
(
ΣˆN−1|N − TN−1ΣˆN−1|N − ΣˆN−1|NTN−1′
)]
+ tr
[
P˜N+1ΣˆN |N
]
,
(2.18)
bN = tr [AN+1QN ] . (2.19)
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Assume (induction hypothesis)
Vt+1 (℘t+1) =
(
αˆt+1|t+1 − αˆt|t+1
)′
At+1
(
αˆt+1|t+1 − αˆt|t+1
)
+ tr
[
At+1Σˆt+1|t+1
]
+ αˆ′t+1|t+1Pt+1αˆt+1|t+1 + tr
[
Pt+1Σˆt+1|t+1
]
+ V θt+1
(
℘θt+1
)
+ bt+1. (2.20)
We show that Vt (℘t) follows the form given in Eq. 2.16 (induction step).
From Eq. 2.12 we know the general form of value function is
Vt (℘t) = min
βt,θt+1
{
Lt(℘t, βt, θt+1) + E
zt+1
[Vt+1 (℘t+1)]
}
, (2.21)
in which the information state at time t + 1, ℘t+1, is a function of ℘t, βt, θt+1, and
zt+1. The expected instantaneous cost in period t, Lt(℘t, βt, θt+1), is given in Eq.
2.13. Application of Lemma II.6 to the expectation in Eq. 2.13 results in
Lt(℘t, βt, θt+1) =
(
αˆt|t − αˆt−1|t
)′
At
(
αˆt|t − αˆt−1|t
)
+ tr
[
At
(
Σˆt|t + Σˆt−1|t − Tt−1Σˆt−1|t − Σˆt−1|tTt−1′
)]
+ β′tBtβt + lt+1(θt+1). (2.22)
Replacing Lt(℘t, βt, θt+1) and Vt+1 (℘t+1) in Eq. 2.21 by their values given by Eq.’s
2.22 and 2.20 respectively, yields
Vt (℘t) = min
βt,θt+1
{(αˆt|t − αˆt−1|t)′At (αˆt|t − αˆt−1|t)
+ tr
[
At
(
Σˆt|t + Σˆt−1|t − Tt−1Σˆt−1|t − Σˆt−1|tTt−1′
)]
+ β′tBtβt + lt+1(θt+1)
+ E
zt+1
[(
αˆt+1|t+1 − αˆt|t+1
)′
At+1
(
αˆt+1|t+1 − αˆt|t+1
)
+ αˆ′t+1|t+1Pt+1αˆt+1|t+1
]
+ tr
[
At+1Σˆt+1|t+1
]
+ tr
[
Pt+1Σˆt+1|t+1
]
+ V θt+1
(
℘θt+1
)
+ bt+1}, (2.23)
Replacing E
zt+1
[(
αˆt+1|t+1 − αˆt|t+1
)′
At+1
(
αˆt+1|t+1 − αˆt|t+1
)]
and E
zt+1
[
αˆ′t+1|t+1Pt+1αˆt+1|t+1
]
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using Lemmas II.10 and II.11 in Appendix 2.7.2, respectively, yields
Vt (℘t) = min
βt,θt+1
{(αˆt|t − αˆt−1|t)′At (αˆt|t − αˆt−1|t)
+ tr
[
At
(
Σˆt|t + Σˆt−1|t − Tt−1Σˆt−1|t − Σˆt−1|tTt−1′
)]
+ β′tBtβt + lt+1(θt+1)
+
(
(Tt − I)αˆt|t +Gtβt
)′
At+1
(
(Tt − I)αˆt|t +Gtβt
)
+ tr
[
At+1
(
TtΣˆt|tTt′ +Qt − Σˆt+1|t+1 − Σˆt+1|t+1Σˆ∗t ′ − Σˆ∗t Σˆt+1|t+1 + Σˆt|t+1
)]
+ (Ttαˆt|t +Gtβt)′Pt+1(Ttαˆt|t +Gtβt) + tr
[
Pt+1
(
TtΣˆt|tTt′ +Qt − Σˆt+1|t+1
)]
+ tr
[
At+1Σˆt+1|t+1
]
+ tr
[
Pt+1Σˆt+1|t+1
]
+ V θt+1
(
℘θt+1
)
+ bt+1}. (2.24)
Canceling terms results in
Vt (℘t) = min
βt,θt+1
{(αˆt|t − αˆt−1|t)′At (αˆt|t − αˆt−1|t)
+ tr
[
At
(
Σˆt|t + Σˆt−1|t − Tt−1Σˆt−1|t − Σˆt−1|tTt−1′
)]
+ β′tBtβt + lt+1(θt+1)
+
(
(Tt − I)αˆt|t +Gtβt
)′
At+1
(
(Tt − I)αˆt|t +Gtβt
)
+ (Ttαˆt|t +Gtβt)′Pt+1(Ttαˆt|t +Gtβt)
+ tr
[
(At+1 + Pt+1)
(
TtΣˆt|tTt′
)]
+ tr [(At+1 + Pt+1)Qt]
+ tr
[
At+1
(
Σˆt|t+1 − Σˆ∗t Σˆt+1|t+1 − Σˆt+1|t+1Σˆ∗t ′
)]
+ V θt+1
(
℘θt+1
)
+ bt+1}.
(2.25)
The terms in Eq. 2.25 can be separated into three types: (1) those terms whose
value are known at time t with information up to time t, (2) those that depend
only on disease control action, βt, and (3) those that depend only on test control
action, θt+1. Hence, the minimization over βt and θt+1 can be separated as Vt (℘t) =
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V
(1)
t (℘t) + V
(2)
t (℘t) + V
(3)
t (℘t) in which
V
(1)
t (℘t) =
(
αˆt|t − αˆt−1|t
)′
At
(
αˆt|t − αˆt−1|t
)
+ tr
[
At
(
Σˆt|t + Σˆt−1|t − Tt−1Σˆt−1|t − Σˆt−1|tTt−1′
)]
+ αˆ′t|t ((Tt − I)′At+1(Tt − I) + Tt′Pt+1Tt) αˆt|t, (2.26)
V
(2)
t (℘t) = min
βt
{βt′ (Bt +Gt′(At+1 + Pt+1)Gt) βt +
(
αˆt|t((Tt − I)′At+1 + Tt′Pt+1)Gt
)
βt
+βt
′ (Gt′(At+1(Tt − I) + Pt+1Tt)αˆt|t)} , (2.27)
V
(3)
t (℘t) = tr
[
(At+1 + Pt+1)
(
TtΣˆt|tTt′
)]
+ tr [(At+1 + Pt+1)Qt] + bt+1
+ min
θt+1
{
lt+1(θt+1) + tr
[
At+1
(
Σˆt|t+1 − Σˆ∗t Σˆt+1|t+1 − Σˆt+1|t+1Σˆ∗t ′
)]
+ V θt+1
(
℘θt+1
)}
.
(2.28)
As before, the minimization over βt is denoted by J˜t, so
J˜t = min
βt
{β′t (Bt +Gt′(At+1 + Pt+1)Gt) βt +
(
αˆ′t|t ((Tt − I)′At+1 + Tt′Pt+1)Gt
)
βt
+ βt
′ (Gt′ (At+1(Tt − I) + Pt+1Tt) αˆt|t)} (2.29)
The minimization over βt can be performed by completion of squares (similar to what
is done in Lemma II.8 for the minimization over βN) to yield Eq.’s 2.30 - 2.33. The
optimal disease control at time t is given by
β∗t = −Utαˆt|t, (2.30)
in which the control law, Ut, is given by
Ut = (Bt +Gt
′(At+1 + Pt+1)Gt)
−1
(Gt
′At+1(Tt − I) +Gt′Pt+1Tt) . (2.31)
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Moreover, the result of minimization over βt is given by
J˜t = −αˆ′t|tP˜t+1αˆt|t, (2.32)
in which
P˜t+1 = ((Tt − I)′At+1Gt + Tt′Pt+1Gt) (Bt +Gt′(At+1 + Pt+1)Gt)−1 (Gt′Pt+1Tt +Gt′At+1(Tt − I)) .
(2.33)
As seen in Eq. 2.30 the optimal disease control β∗t is a linear function of the filtered
state mean αˆt|t. It is worth noting that this function (more precisely, the control law
Ut) depends only on parameters of the system dynamics and the objective function
cost inputs. Hence, the control law is data independent and can be calculated off-line
prior to solving the measurement and control problems.
As seen in Eq.’s 2.4 to 2.11, the optimal state estimation is independent of the control
law. We also just showed that the optimal control law is independent of the state
estimation. This completes proof of the Theorem II.1. 
Replacing the minimization over βt in Eq. 2.27 by its value given by Eq. 2.32 results
in
Vt (℘t) =
(
αˆt|t − αˆt−1|t
)′
At
(
αˆt|t − αˆt−1|t
)
+ tr
[
At
(
Σˆt|t + Σˆt−1|t − Tt−1Σˆt−1|t − Σˆt−1|tTt−1′
)]
+ αˆ′t|t
(
(Tt − I)′At+1(Tt − I) + Tt′Pt+1Tt − P˜t+1
)
αˆt|t + tr
[
(At+1 + Pt+1)
(
TtΣˆt|tTt′
)]
+ min
θt+1
{lt+1(θt+1) + tr
[
At+1
(
Σˆt|t+1 − Σˆ∗t Σˆt+1|t+1 − Σˆt+1|t+1Σˆ∗t ′
)]
+ V θt+1
(
℘θt+1
)}
+ tr [(At+1 + Pt+1)Qt] + bt+1. (2.34)
Letting
Pt = (Tt − I)′At+1(Tt − I) + Tt′Pt+1Tt − P˜t+1, (2.35)
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and replacing tr
[
(At+1 + Pt+1)
(
TtΣˆt|tTt′
)]
in Eq. 2.34 by its other form given by
Lemma II.12, Eq. 2.34 can be written as follows to match the form of value function
we claimed in Eq. 2.16.
Vt (℘t) =
(
αˆt|t − αˆt−1|t
)′
At
(
αˆt|t − αˆt−1|t
)
+ tr
[
AtΣˆt|t
]
+ αˆ′t|tPtαˆt|t + tr
[
PtΣˆt|t
]
+ tr
[
At
(
Σˆt−1|t − Tt−1Σˆt−1|t − Σˆt−1|tTt−1′
)]
+ tr
[(
P˜t+1 + At+1Tt + Tt
′At+1 − I
)
Σˆt|t
]
+ min
θt+1
{lt+1(θt+1) + tr
[
At+1
(
Σˆt|t+1 − Σˆ∗t Σˆt+1|t+1 − Σˆt+1|t+1Σˆ∗t ′
)]
+ V θt+1
(
℘θt+1
)}
+ tr [(At+1 + Pt+1)Qt] + bt+1. (2.36)
Now, by comparing Eq.’s 2.36 and 2.16, it can be easily seen that for t = 1, . . . , N −1
V θt
(
℘θt
)
= tr
[
At
(
Σˆt−1|t − Tt−1Σˆt−1|t − Σˆt−1|tTt−1′
)]
+ tr
[(
P˜t+1 + At+1Tt + Tt
′At+1 − I
)
Σˆt|t
]
+ min
θt+1
{lt+1(θt+1) + tr
[
At+1
(
Σˆt|t+1 − Σˆ∗t Σˆt+1|t+1 − Σˆt+1|t+1Σˆ∗t ′
)]
+ V θt+1
(
℘θt+1
)},
(2.37)
and
bt = tr [(At+1 + Pt+1)Qt] + bt+1, (2.38)
while from Eq.’s 2.18 and 2.19 we know for t = N
V θN
(
℘θN
)
= tr
[
AN
(
ΣˆN−1|N − TN−1ΣˆN−1|N − ΣˆN−1|NTN−1′
)]
+ tr
[
P˜N+1ΣˆN |N
]
,
(2.39)
and
bN = tr [AN+1QN ] . (2.40)
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Hence, proof of the Theorem II.3 (i.e., the value function we claimed in Eq. 2.16) is
complete. 
Note that the dynamic program defined by value function V θt
(
℘θt
)
for t = 1, . . . , N can
be solved using a branch-and-bound-type algorithm to find the optimal monitoring
schedule. The elements of this dynamic program, in a succinct form, are as follows.
*Information state: ℘θt =
(
Σˆt|t, Σˆt−1|t
)
*Action space: θ ∈ Θ where Θ is the set of all available tests for the corresponding
disease.
*System dynamics are given by Eq.’s 2.8, 2.9, and 2.11.
*Optimality equation is given by Eq. 2.37.
*Boundary condition is given by Eq. 2.39.
This completes proof of the Theorem II.2. 
2.5 Case Study of Glaucoma
Thus far we have presented the modeling framework in its general form and derived
the optimal disease and test control actions. In this section, we provide a proof of
concept by applying our approach to glaucoma and demonstrating how it can help
guide clinicians tailor their disease monitoring and treatment control.
Glaucoma is a major public health problem affecting almost 3 million patients in
the United States (Vajaranant et al. 2012) and over 60 million patients worldwide
(Tham et al. 2014). Glaucoma is the second leading cause of blindness in the US
and a leading cause of visual impairment among Americans (Stein et al. 2011). In
this section we show how the modeling framework and solution approaches described
in Sections 2.3 and 2.4 can be applied to help clinicians in caring for patients with
glaucoma. Further, we will elaborate on additional features of our approach designed
specifically for glaucoma. Numerical results presented in this section are based on
data from patients who were enrolled in two large glaucoma clinical trials.
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2.5.1 Glaucoma
Glaucoma is a progressive eye disease which can cause irreversible vision loss and
blindness if not adequately monitored and treated. From a societal perspective, the
direct medical costs of managing glaucoma are estimated to total over 2.86 billion
USD annually (Rein et al. 2006). Further, on a per patient basis, costs more than
quadruple when patients progress from early to advanced glaucoma (Lee et al. 2006).
The main risk factors associated with glaucoma and its progression include: non-
white race, older age, elevated IOP, genetics and family history (Tielsch et al. 1990).
It is worth noting that the patient’s IOP (i.e., the pressure inside the eye) is the only
known controllable/modifiable glaucoma risk factor. Therefore, the current manage-
ment of glaucoma focuses on lowering the eye pressure by establishing a “target IOP”,
which is the level of IOP that the clinician feels is low enough to sufficiently slow dis-
ease progression (Jampel 1997).
Patients with glaucoma are monitored for disease progression using quantitative tests.
Two primary methods to monitor a patient include: (1) tonometry (or measuring the
IOP), and (2) perimetry (or visual field (VF) testing). Tonometry measures the pa-
tient’s IOP, is relatively easy to perform, and is part of a standard eye examination.
In most patients, vision loss occurs because elevated IOP damages the optic nerve, the
structure that carries visual information to the brain for processing (Sommer et al.
1991). Lowering IOP reduces the chances of glaucoma progression. With glaucoma,
patients often progressively lose peripheral vision and eventually central vision. The
VF test quantifiably measures the extent and rate of peripheral vision loss by examin-
ing the sensitivity of the eye to light stimuli. It is more time-consuming than checking
IOP, but provides important information on the status of the disease. VF testing can
be anxiety provoking and challenging as it requires patient attention and cooperation.
Two key global performance measures from VF testing include Mean Deviation (MD)
and Pattern Standard Deviation (PSD), which estimate the deviation of peripheral
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vision from a reference population who do not have glaucoma (Choplin and Edwards
1995). MD is usually a negative number; higher values of MD (i.e., values closer to
zero) correspond to better vision quality (less vision loss). PSD is usually a positive
number; lower values of PSD indicate less glaucomatous damage.
It is well established from prior work that both IOP and VF tests can be associated
with noise. For example, patient performance on automated VF test can fluctuate
considerably from one test to the next (Choplin and Edwards 1995). Likewise, IOP
can fluctuate from hour to hour and day to day (Wilensky et al. 1993). To take such
noise into consideration in deciding how to optimally monitor the patient and deter-
mine a target IOP, we harness the Kalman filter method (Kalman 1960) to extract
noise from the raw measurements.
There are a number of treatments available to lower the IOP for a patient with glau-
coma. Different eye drops, laser therapies, and incisional surgery can reduce the IOP
to any number above 6 mmHg. However, glaucoma medications can be expensive
and can have serious side effects including stinging, blurred vision, eye redness, itch-
ing, burning, low blood pressure, reduced pulse rate, fatigue, shortness of breath,
headache, and depression. Therefore, it is important to find a target IOP level for
each patient that sufficiently slows progression while avoiding unnecessary treatment.
It is common in current practice to use fixed-interval monitoring regimes (e.g., an-
nual exams) to test for disease progression. Furthermore, for each patient and eye,
the ophthalmologist must currently make a gestalt-based estimate of a reasonable tar-
get IOP that considers the risk of disease progression and the side effects and costs
associated with lowering the IOP. To our knowledge, no optimization-based approach
presently exists to jointly determine how to monitor a patient with glaucoma and
how to control the disease. Our approach considers the history of the patient (prior
test performances) and her unique disease dynamics to provide clinicians with (1) a
personalized monitoring regime to achieve an accurate assessment of whether there
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is disease progression (exploration), and (2) a menu of target IOP options and how
the glaucoma is likely to progress for different target IOP levels that the doctor can
leverage to devise a treatment plan for the patient (exploitation). As a feature of our
model, the clinician is able to select the desired aggressiveness level to monitor and
treat the patient based on the unique characteristics/circumstances of each individ-
ual. We will elaborate on this menu of options in Subsection 2.5.5.
Figure 2.2 depicts a high-level overview of our dynamic monitoring and control deci-
sion support framework for patients with glaucoma. At each office visit, IOP and/or
VF test(s) are performed. The raw data from these tests (which are known to be
noisy) are fed into a Kalman filter to obtain an optimal estimation of the current
disease state for a particular eye. Then, the estimate of the previous state is refined
via a Kalman smoother given the new information. Each patient’s label/type (fast,
slow, or non-progressor) is determined to estimate how quickly the patient is likely
to progress in the future. The decision support tool provides an optimal monitoring
schedule (i.e., the timing of the next exam/test and which tests the patient should
take) and a personalized target IOP for the patient for different aggressiveness lev-
els/options (super-high, high, moderate, low, or super-low). Finally, the clinician
chooses an aggressiveness option from the menu of choices that is appropriate for the
individual patient.
2.5.2 Patient Disease State
We use a nine-dimensional state vector, αt, to model the patient’s disease state.
The elements of the state vector include Mean Deviation (MD), Pattern Standard
Deviation (PSD) and Intraocular Pressure (IOP) together with their discrete time
first and second derivatives (i.e., velocity and acceleration, respectively);
αt =
[
MD MD′ MD′′ PSD PSD′ PSD′′ IOP IOP ′ IOP ′′
]′
. (2.41)
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Figure 2.2: Big picture of the decision support framework illustrating the model in-
puts and outputs as well as the sequence of main steps of the disease
monitoring and control algorithm.
The non-linear behavior of the disease dynamics is captured by including the velocity
and acceleration of key disease state elements in the state vector. This is known to
be an effective way to linearize a nonlinear model of state evolution (see Bertsekas
et al. 1995). MD′, PSD′, and IOP ′ are the slope of a linear regression of the latest
three MD, PSD, and IOP measurements, respectively. MD′′, PSD′′, and IOP ′′ are
the difference of the latest two MD′, PSD′, and IOP ′ values divided by the time
interval between them.
2.5.3 Data
To parameterize and validate our model, we use data from two multi-center ran-
domized clinical trials: the Collaborative Initial Glaucoma Treatment Study (CIGTS)
(Musch et al. 1999) and the Advanced Glaucoma Intervention Study (AGIS) (Ederer
et al. 1994). These data sets are chosen because they include structured tonome-
try and perimetry data (IOP and VF readings) of glaucoma patients taken every 6
months during the course of the trials. We match the time step of our LQG model
with these data sets to avoid the need for data interpolation (i.e., there is a 6-month
time interval between periods t and t+ 1 in our model).
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CIGTS followed newly-diagnosed glaucoma patients with mild to moderate disease
who were randomized to medical or surgical therapy and followed for up to 11 years
with IOP and VF tests taken every 6 months to assess for disease progression. In
AGIS, patients with advanced glaucoma were randomized to laser therapy or inci-
sional surgery and followed for up to 11 years with IOP and VF readings taken every
6 months.
For the purpose of the case study, we excluded patients from these trials with fewer
than 5 readings. We also restricted our focus to the patients who received either
medical or laser therapy, and excluded glaucoma patients who received incisional
surgical interventions, because incisional surgery can abruptly change disease pro-
gression dynamics. We randomly divided all eligible participants from the trials (571
participants) into two sets of equal size: (1) a training set, and (2) a testing set. Both
sets have approximately the same number of mild, moderate, and advanced glaucoma
patients, with similar number of white and black patients, and equal numbers of pa-
tients contributing data from each trial. The training set is used for parametrization
and calibration of our state space model and the testing set is used to evaluate the
performance of our approach.
2.5.4 Patient Types (Fast/Slow/Non-progressor)
A fast-progressing patient is someone whose glaucoma is rapidly worsening and is
part of the subset of patients at greatest risk of blindness. Although there is presently
no gold standard for defining glaucoma fast-progressors, prior literature considers a
loss of MD greater than 1 dB per year as a reasonable identifying feature of patients
who are exhibiting fast-progression of glaucoma (see Heijl et al. 2013; Gardiner and
Crabb 2002). We built our algorithms based on this definition of fast-progressors.
To classify each patient, we calculated the slope obtained from a linear regression of
their entire set of MD readings and labeled them as a:
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• fast-progressor if the MD progression slope is declining by ≥ 1 dB/year,
• slow-progressor if the MD progression slope is declining between 0 and 1 dB/year,
and
• non-progressor if the MD progression slope is not declining.
2.5.5 Aggressiveness Levels/Options/Policies
In clinical practice, the goals of care must be tailored to the needs of the in-
dividual patient. Rather than proposing one solution, a more powerful and useful
approach is to provide the clinician with a range of options for how much effort (both
from provider and the patient) will be put into monitoring and how aggressively IOP
should be lowered such that future progression can be slowed. For instance, clinicians
will likely see the need to monitor and treat a young patient who only has sight in one
eye more aggressively than an older patient with good vision in both eyes who has
multiple systemic medical comorbidities and is likely to expire before they go blind
from glaucoma. As a useful and not overly complex approach, we develop optimiza-
tion models tailored to three regimes, or “options,” for monitoring and treatment
(suggested by our clinical collaborator for ease of adoption into clinical practice). We
refer to these three options as low, moderate, and high levels of aggressiveness to rep-
resent the level of intensity in care and monitoring. We also define two extreme levels
of aggressiveness: super-high and super-low. Note that we choose these terms only
for convenience in presenting the five options and to make it easier for the reader to
remember the order of them in terms of how aggressively they test and treat patients;
they are not meant to correspond to any existing terms or approaches currently used
in clinical practice. These five options are useful not only for sensitivity analysis, but
also suggest an effective way to implement a decision support system so that clinicians
can pursue monitoring and treatment with the level of intensity that they, together
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with the patient, determine to be the most appropriate for each individual. The five
aggressiveness levels/policies/options follow:
1. Super-high aggressiveness option, which drops the IOP immediately to 6 mmHg
(an ideal level of IOP for patients with any severity of glaucoma, but one that
may be impractical for many patients due to limitations with the effectiveness
of existing interventions, side effects, and/or complications),
2. High aggressiveness option, which tends to lower the IOP by 40%-60% compared
to the patient’s treated level of IOP that was achieved in the CIGTS/AGIS
clinical trials after the initial intervention was given,
3. Moderate aggressiveness option, which tends to lower the IOP by 20% to 40%
compared to the patient’s treated level of IOP that was achieved in the CIGTS/AGIS
clinical trials after the initial intervention was given,
4. Low aggressiveness option, which corresponds to the IOP achieved under no
additional interventions beyond those employed in the CIGTS/AGIS trials,
5. Super-low aggressiveness option, which attempts to estimate progression of an
untreated patient with glaucoma by removing the effect of existing interventions
that were employed in CIGTS/AGIS on the patient’s IOP.
It should be noted that the exact amount of IOP control suggested by high, moder-
ate, and low aggressiveness policies is patient-specific and is optimized to yield the
minimum total cost as defined by the objective function. However, the super-high
and super-low aggressiveness policies are static policies that do not take the objective
function into account. They are mainly added for purposes of analysis and compari-
son, but they can still provide valuable insight in a clinical setting by presenting the
clinician the “best” and “worst” case options and their forecasted impact on disease
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progression dynamics. These five options/policies also provide sensitivity analysis on
the model cost parameters.
2.5.6 System Model Parameterization
The Expectation Maximization (EM) algorithm was employed for parameteriza-
tion of our state space model. EM is an iterative algorithm for finding the maximum
likelihood estimate of model parameters in the presence of missing or unobserved data.
The EM algorithm alternates between expectation step (E-step) and maximization
step (M-step). In the E-step, raw, noisy readings are filtered and missing data is esti-
mated based on the observed data and the most recent estimate of system parameters.
In the M-step, the log-likelihood function of all data points is maximized assuming
the missing data is given by the estimates from the E-step. For more information
about the EM algorithm please see Dempster et al. (1977); Digalakis et al. (1993);
Ghahramani and Hinton (1996). While the model was presented in its general setting
in Section 2.3, for the purpose of this case study we assume the model parameters are
time-invariant. The output of the EM algorithm is the best estimate of system ma-
trices Tt = T , Qt = Q, Zt = Z, H
(θt)
t = H
(θt) for t = 1, . . . , N , and initial state mean
and covariance, αˆ0 and Σˆ0 (see Subsections 2.3.1 and 2.3.2 for the definition of these
parameters). We further assume that Gt = G =
[
0 0 0 0 0 0 1 0 0
]′
T for
t = 1, . . . , N , because the control variable βt is designed to control only the patient’s
IOP, which is the only controllable glaucoma risk factor. Furthermore, it is known
that the intervention started or employed at time t has instantaneous effect on lower-
ing the patient’s IOP. For example, if patient’s IOP is 20 mmHg at time period 7 and
the control β∗7 = −3 mmHg, the expected value of IOP right after time period 7 is 17
mmHg. This IOP reduction affects other state elements and progression dynamics in
the following time period through the transition equation. We use the EM algorithm
to obtain 4 sets of system parameters. These sets of parameters are obtained from
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(1) all patients in the training set, (2) only fast-progressors, (3) only slow-progressors,
and (4) only non-progressors.
The model cost parameters were estimated based on the input from our glaucoma
specialist collaborator so that the model outputs are reasonable from a clinical per-
spective. Note that it is the relative costs (rather than each absolute cost) that plays
a key role in our analysis. It is beyond our scope to obtain definitive cost parame-
ters; however, signicant sensitivity analysis was performed around those estimates to
better understand the model’s behavior and to ensure that the model in its entirety
provides credible decision support. We confirmed with our glaucoma specialist col-
laborator that the model generates reasonable target IOPs and monitoring schedules
for each patient. For instance, under the high aggressiveness option the model for
fast-progressing patients (i.e., the most aggressive combination) should suggest taking
both IOP and VF tests every six months and a target IOP of around 6 to 9 mmHg.
Under the low aggressiveness option the model for non-progressing patients (i.e., the
least aggressive combination) should suggest no further IOP reduction and taking
IOP and VF tests every two years. This is in line with recommendations put forth
by the American Academy of Ophthalmology Glaucoma Panel (2010). For all other
combinations of aggressiveness level and patient type the model cost parameters are
fine-tuned so that it suggests a monitoring regime and target IOP level that are rea-
sonable in expert clinical opinion and are in between the two extreme combinations.
The behavior of optimal policies is discussed in more detail in Section 2.5.8.2.
2.5.7 Model Usage for a Glaucoma Patient
For a patient who is newly diagnosed with glaucoma with no prior history of IOP
and VF readings, both tests are taken in every period (i.e., every 6 months) for the
first 5 periods. Gardiner and Crabb (2002) found that predictions based on 5 initial
VF test results is a reasonable predictor of future vision loss in most patients. These 5
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readings are used to (1) obtain baseline values for key disease state elements (i.e., MD,
PSD, and IOP), (2) calculate the velocities and accelerations of key state elements,
(3) warmup the Kalman filter and smoother, (4) reduce the initial uncertainty sur-
rounding a given patient’s disease state, (5) calculate the initial 5-period rate/slope
of MD progression to label the patient as fast, slow, or non-progressor, and (6) differ-
entiate the patient from the population mean and tailor the disease transition model
to the specific patient. If the patient already has a history of IOP and VF readings,
then these values can be used to create the initial state, or warmup, for our model.
The system parameters obtained from all training patients are used in the Kalman fil-
ter and the Kalman smoother during the warmup period. At the end of the warmup
period (i.e. after 5 readings), the patient is labeled as a fast-progressor, a slow-
progressor, or a non-progressor based on her MD progression rate. Thereafter, only
the type-specific system parameters (i.e., fast, slow, or non-progressor set of param-
eters) are used in the Kalman filter and smoother. Each time a test is taken, the
MD progression slope is recalculated. We always consider the latest 5 filtered MD
values to update the MD slope (i.e., a sliding window of length 5). Whenever the
patient’s latest MD slope indicates a label upgrade (i.e., the patient moves from non-
progressor to slow/fast-progressor, or from slow-progressor to fast-progressor), the
model (1) calls for a follow-up visit to take IOP and VF testing in the following
time period, and (2) labels the patient as a suspect of the higher label/category (e.g.,
slow-progressor suspect or fast-progressor suspect). If the label change is confirmed
at the next follow-up visit, the higher label is assigned to the patient; otherwise, the
patient is returned to the previous lower label status. Note that in our analyses, we
take a conservative approach and do not allow any label downgrading (on the recom-
mendation of our glaucoma specialist collaborator). Once the label is upgraded for a
patient, the model will recommend applying more IOP control (i.e., greater intensity
of interventions) to slow glaucoma progression. Therefore, it can be expected that
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the MD will tend to decline less rapidly once the amount of IOP control is increased,
thus resulting in a lower classification/label at some point. However, if we were to
downgrade the patient’s label and let the model decrease the amount of IOP control,
the patient would be at risk to start losing vision at the same rate as earlier in the
disease course, which is not desirable. Therefore, we do not allow label downgrading
for any patient once the label upgrade is confirmed. If a patient suspected to belong
to a higher category does not get a confirmatory result at the very next follow-up
visit, then, the patient remains at the original/lower label he/she was previously at.
The glaucoma monitoring and treatment control algorithm steps are illustrated in
Figure 2.3.
2.5.8 Numerical Results
In this subsection, we test the performance of our dynamic disease monitoring
and control algorithm on glaucoma patients of CIGTS and AGIS clinical trials. We
first validate our prediction model on the testing dataset, using the training dataset
for parameterization. Then, we provide numerical results and examples on how the
optimal policies behave. Lastly, we provide further results on the impact of optimal
policies on patients with glaucoma.
2.5.8.1 Validation:
We first validate that the model is good at forecasting future disease progression
trajectory and then validate that the results are consistent with clinical expectations.
Our modeling approach efficiently captures the system and measurement noises using
a set of stochastic first-order vector difference equations. To evaluate the performance
of our prediction model, we used the first five data points of each patient in the
testing dataset to warm up the Kalman filter and determine the patient type. Then,
we predicted MD values for five periods into the future for each patient type (fast-
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Figure 2.3: Glaucoma monitoring and treatment control flow diagram.
progressor, slow-progressor, and non-progressor) and calculated the prediction error
(i.e., the predicted state mean minus the actual reading as obtained from the patients
during their followup in the trial). Figure 2.4 shows the mean MD prediction error for
up to five periods (2.5 years) into the future (each period represents a 6 month time
interval). The dots correspond to the mean error and the bars represent the 95%
confidence interval for the mean. These interval plots confirm that our prediction
model has very little error in predicting the glaucoma state progression. One also
sees that the fast-progressors (as defined in Subsection 2.5.4) vary the most in the
datasets, and this is reflected in greater uncertainty and error. In here, we present
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Figure 2.4: Interval plot of mean MD prediction error for different prediction lengths.
The dots correspond to mean error and the bars represent 95% confidence
interval for the mean.
the results for MD as it is the most clinically useful state variable. Similar results
were obtained for other state elements (PSD and IOP).
2.5.8.2 Evaluation of the Optimal Policies:
Now that we have confirmed that the model creates an accurate forecast of dis-
ease progression, we next test that the output provides clinically reasonable results
as confirmed by our clinical collaborator. The structure of optimal IOP control gen-
erated by our model under the moderate or high aggressiveness policy is a key to
identifying the target IOP for each patient. We applied the high and moderate ag-
gressiveness policies to all fast and slow-progressing patients in the test dataset to
achieve a statistical characterization of how each policy behaves. For each group and
each aggressiveness policy, we used the first five data points to warmup our model.
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We then recorded the amount of optimal IOP control suggested by our model in the
next 20 time periods (i.e., the following 10 years). Figure 2.5 depicts the results over
all the patients in the testing dataset as box plots of optimal additional IOP control
(β∗t ) applied in the current (i.e., period 0) and the following time periods. An IOP
control of −x mmHg corresponds to lowering the patient’s IOP by x mmHg more
than what was achieved in AGIS/CIGTS. The bottom and top of each box are the
first and third quartiles, respectively. The lower and upper whiskers extend to the
minimum and maximum data points within 1.5 box heights from the bottom and top
of the box, respectively. As seen in the figure, our feedback-driven model recommends
further lowering the IOP within the first few time periods. Afterwards, the optimal
additional IOP control is close to zero. This results in the patient’s IOP converging
to “a number” over time. We call this number the “target IOP,” per the common
terminology used in the glaucoma community. As one would expect, the group of
non-progressing patients do not get additional benefit from further lowering their
IOP since they exhibit no signs of progression at the IOP levels they are maintaining
from the treatments already employed in the trials. Therefore, they are not included
in the graph.
We applied the five aggressiveness options to fast and slow-progressing patients in
the test dataset and obtained the following IOP-related metrics for each combination
of patient type and aggressiveness policy: (1) target IOP [mmHg] or the 10-year pre-
dicted IOP, (2) additional IOP control [mmHg] applied in 10 years (representing the
amount/intensity of treatment), and (3) percentage of IOP change after 10 years. For
each metric, we report the median and interquartile range (IQR), which are robust
measures of location and scale respectively. The IQR is the difference between the
upper and lower quartiles and provides a range that contains 50% of the data. As
seen in Figure 2.5, the optimal additional IOP reduction is almost entirely applied
during the first 6 periods (3 years) of employing the control policy. Hence, we evaluate
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Figure 2.5: Optimal IOP controls suggested by our model for fast and slow-
progressing patients under the high and moderate aggressiveness policies
over 10 years. Period 0 is the current time period (i.e., the period at
which the IOP control starts).
the patient’s IOP after 10 years, which is a sufficiently long horizon for the IOP to
become stable under treatment. We tested our IOP control model with longer time
horizons and obtained similar results.
Table 2.1 summarizes the IOP-related results. For instance, applying the high ag-
gressiveness policy to fast-progressors results in a median target IOP of 7.17 mmHg;
this can be achieved by administering a median additional 9.36 mmHg IOP reduction
from the baseline level of IOP attained in the trials. Such a target IOP is, on aver-
age, 55.24% lower than the baseline IOP (the IOP at the beginning of the 10-year
prediction period) of fast-progressing patients in the trials. Since target IOP is an
important metric that helps guide clinicians in selecting the appropriate treatment
plan for the patient, the distribution of target IOPs is also given in Figure 2.9 in
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Table 2.1: Comparison of the effect of different aggressiveness options on patient’s
IOP for fast and slow-progressing patients in CIGTS and AGIS.
Appendix 2.7.3.
Table 2.2 summarizes the optimal monitoring regime for different combinations of
patient type and aggressiveness level. For example, under the moderate aggressive-
ness level, the model for slow-progressing patients recommends measuring IOP every
6 months and checking the visual field every 12 months. It is worth noting that these
protocols remain optimal as long as (1) the patient follows the monitoring schedule
(i.e., does not miss a test), (2) the patient type/label remains unchanged, and (3) the
doctor does not change the aggressiveness level. If any of the three criteria is not met,
the model modifies the monitoring schedule to account for the missing information or
the change in patient label/aggressiveness level. The monitoring regimes presented in
Table 2.2 and the range and mean of target IOPs presented in Figure 2.9 are clinically
appropriate in the professional opinion of our glaucoma specialist collaborator.
2.5.8.3 Menu of Options:
Now that we have validated our model and elaborated on the structure of the op-
timal policies, we provide an example of how our decision support tool can help guide
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Table 2.2: Optimal monitoring regime for different combinations of patient type and
aggressiveness level.
clinicians in managing a patient with glaucoma. Figure 2.6 depicts the glaucoma pro-
gression trajectory (change in MD over time) for a randomly chosen fast-progressing
patient from the AGIS trial. The figure depicts a sample output of the decision sup-
port tool (in regards to disease control) that compares how this patient is likely to
progress over the following 10 periods (5 years) under different aggressiveness options
defined in Subsection 2.5.5. As demonstrated in the figure, the patient progresses
much slower and would have better MD value (i.e., vision quality) 5 years into the
future as the aggressiveness of IOP control is increased. This graph demonstrates the
type of insight our decision support tool can offer the clinicians. It provides a menu
of options related to how aggressively the doctor wants to treat the patient, depicts
the future disease progression trajectory, and provides the optimal target IOP and
monitoring schedule for each aggressiveness option. The doctor is then able to select
the right aggressiveness option based on evolving needs of the patient, adherence,
health status, and other personal or clinical factors.
2.5.8.4 Insights into Treatment Effectiveness by Patient Type:
Figure 2.7 graphs the average MD loss per year against the total IOP reduction ap-
plied under different aggressiveness policies for all fast and slow-progressing patients
in the test set of CIGTS and AGIS trials. This graph provides important insights
for managing patients with glaucoma: (1) As seen in the graph, the curve for fast-
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Figure 2.6: An example of the trajectory of glaucomatous progression as captured
by changes to MD over time by employing each of the five different ag-
gressiveness policies for a sample fast-progressing patient from the AGIS
study (note: higher MD correlates with better vision quality).
progressors has a steeper slope, which indicates that this group of glaucoma patients
benefits the most from further lowering of IOP. (2) It can be deduced from Figure
2.7 that the low aggressiveness policy (point B), which roughly speaking corresponds
to treatment using eye drops, works well enough for most slow-progressors since the
curve is fairly flat around point B on the slow-progressors curve. In other words,
increasing the aggressiveness level from low to moderate/high has only minimal ad-
vantage for this group of patients. This highlights the importance of differentiating
patients by progression type. Treating all patients the same risks over-treating for
little gain or irreversible vision loss due to under-treating. It can also be seen that
slow-progressors gain long-term benefit if treated under the super-high aggressiveness
policy (point E), which roughly speaking corresponds to incisional surgery. There-
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Figure 2.7: Average MD loss per year can be reduced by applying more IOP control.
Fast-progressors get more benefit from lowering their eye pressure.
fore, for slow-progressing patients, the doctor may choose either the low or super-high
aggressiveness policy, depending on the individual’s life expectancy, severity of glau-
coma, other personal and medical factors, and the preferences of the patient. (3)
The steep slope of the fast-progressors’ curve around point B implies that vision loss
could be significantly averted (even in the short-term) by further reduction of their
IOP. Hence, moderate, high, or super-high aggressiveness policies (points C, D, and E
on the graph, respectively) may be more suitable for most fast-progressing glaucoma
patients.
The same result is also verified by plotting the MD loss averted over 10 years by fol-
lowing the IOP controls suggested by our model. Please see Figure 2.10 in Appendix
2.7.3.
2.5.8.5 Sample Application of the Model in Practice:
In this subsection, we provide an illustration of how our modeling framework may
be used to guide monitoring and control of a glaucoma patient. Figure 2.8 portrays
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the disease trajectory of a sample patient. After the warmup period (i.e., the first
5 periods) the patient is initially identified as a non-progressor. In our example, the
clinician chooses the low aggressiveness option to monitor and control the patient.
Subsequently, the model suggests taking an IOP reading every year and a VF test
every other year. We assume the clinician and the patient follow this protocol. The
patient remains a non-progressor up to period 13, when she becomes classified as a
slow-progressor suspect. This slow-progressor status is confirmed after obtaining IOP
and VF testing at a follow-up visit in time period 14. When the patient becomes a
confirmed slow-progressor, for the sake of this example, assume the doctor decides to
increases the aggressiveness level to the moderate aggressiveness policy. Under this
policy, the model recommends (1) lowering the IOP from 24 to about 21 mmHg, (2)
measuring the IOP every six months, and (3) taking a VF test every year. After
1.5 years (i.e., at time period 17) the doctor and patient decide to further increase
the aggressiveness level and continue care under the high aggressiveness policy. This
policy suggests taking both IOP and VF tests every six months and recommends
additional IOP reduction. Figure 2.8 also illustrates how the patient’s glaucoma
would likely progress after period 14 should the doctor have maintained the low
aggressiveness IOP control policy during periods 5-14.
While this example relates to the management of a single patient, a few aspects should
be highlighted. (1) As described in Subsection 2.5.7, glaucoma patients do not always
maintain the same progression rate over time. Recall that each time a test is taken,
the model updates the MD slope estimate; hence, it is possible that a patient moves
from non-progressor status to slow/fast-progressor, or from slow-progressor to fast-
progressor status. (2) As described in Subsection 2.5.8.2, whenever the patient’s label
is changed or the doctor decides to change the aggressiveness level, the model modifies
the monitoring regime subsequently. (3) As described in Subsection 2.5.8.4, there is
little gain (in terms of preventing vision loss) in increasing the aggressiveness level
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Figure 2.8: A non-progressing patient becomes slow-progressor. The clinician tailors
care by increasing the aggressiveness level. The first 5 periods are warmup
time. From period 5 to 13, the patient is a non-progrssor and the doctor
selects the low aggressiveness policy. In period 13, the patient becomes a
slow-progressor suspect and this label upgrade is confirmed in period 14.
The doctor treats the patient under moderate aggressiveness policy from
period 14 to 17. In period 17, the doctor increases the aggressiveness
plociy to high in order to further slow the progresson rate. Periods 14-25
show forecasted values.
from low to high for slow progressing patients. Note the big gap in the optimal IOP
under the low and high aggressiveness policies at time period 25. However, this gap
results in a very small difference in the patient’s MD values. Benefiting from this type
of insight in a busy clinic can significantly enhance the ability of ophthalmologists
and optometrists to appropriately take care of patients with glaucoma.
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2.6 Conclusions
In this chapter we developed a dynamic personalized modeling paradigm for si-
multaneous monitoring and control of irreversible chronic diseases (e.g., glaucoma).
Our model incorporates each patient’s past and present readings in a feedback-driven
control model to provide the jointly optimal solution to two critical questions fac-
ing clinicians: (1) when to schedule office visits and which suite of tests to perform
to monitor for disease progression (exploration); and (2) what levels of controllable
disease risk factors should be targeted to slow the rate of disease progression (ex-
ploitation).
Kalman filtering methodology is built into our modeling framework to extract noise
from the raw measurements and to optimally estimate the disease state in each time
period based on imperfect observations. This is a key to accurately identifying genuine
disease progression from testing artifacts. We developed a multivariate continuous
state space model of disease progression and model the state transition and the test-
ing processes as first order vector difference equations with multivariate Gaussian
random noises. For the new objective of minimizing the relative change in state (i.e.,
disease progression), which is imperative for management of irreversible chronic dis-
eases, we proved the two-way separation of optimal estimation and control. This is a
fundamental finding upon which solution tractability depends.
To demonstrate the effectiveness of our approach, we harnessed data from two land-
mark glaucoma randomized clinical trials to parametrize and validate our model.
We showed that our Kalman filter-based model has low error in predicting the future
disease progression trajectory. Further, we showed that our decision support tool pro-
vides a menu of options for the clinician based on how aggressively the doctor wants
to manage the patient. For each aggressiveness option, the model provides for each
glaucoma patient (1) future disease progression trajectory, (2) optimal monitoring
schedule, (3) optimal target IOP. The doctor has the choice to select an appropriate
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aggressiveness level depending on the patient’s life expectancy, severity of glaucoma,
and other personal and clinical factors. Our numerical results demonstrated that
following the recommendations of our model not only results in patients with bet-
ter vision quality over the treatment horizon, but also achieves significantly slower
glaucoma progression rate, which means patients will keep their sight longer.
2.7 Appendix
2.7.1 Optimization of the Final Period Disease Control Action
The value function in the last period is given by
VN (℘N) = min
βN
{E [(αN − αN−1)′AN (αN − αN−1)]+ βN ′BNβN
+ E
[
(αN+1 − αN)′AN+1 (αN+1 − αN)
]}. (2.42)
ReplacingE
[
(αN − αN−1)′AN (αN − αN−1)
]
and E
[
(αN+1 − αN)′AN+1 (αN+1 − αN)
]
by their values given by Lemmas II.6 and II.7 in Appendix 2.7.2 respectively, and
combining terms results in
VN (℘N) =
(
αˆN |N − αˆN−1|N
)′
AN
(
αˆN |N − αˆN−1|N
)
+ αˆ′N |N
(
(TN − I)′AN+1(TN − I)
)
αˆN |N
+ tr
[
AN
(
ΣˆN |N + ΣˆN−1|N − TN−1ΣˆN−1|N − ΣˆN−1|NTN−1′
)]
+ tr
[
AN+1
(
(TN − I)ΣˆN |N(TN − I)′ +QN
)]
+ min
βN
{βN ′(GN ′AN+1GN +BN)βN + βN ′(GN ′AN+1(TN − I)αˆN |N)
+ (αˆ′N |N(TN − I)′AN+1GN)βN}, (2.43)
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where tr represents the trace of the matrix. Let the minimization term in Eq. 2.43
be denoted by J˜N . That is, let
J˜N = min
βN
{βN ′(GN ′AN+1GN +BN)βN + βN ′(GN ′AN+1(TN − I)αˆN |N)
+ (αˆ′N |N(TN − I)′AN+1GN)βN}. (2.44)
This minimization can be performed by completion of squares as described in Lemma
II.8 in Appendix 2.7.2. Eq.’s 2.45 - 2.48 give the optimum disease control β∗N and the
result of minimization J˜N . The optimum disease control at time N is given by
β∗N = −UN αˆN |N , (2.45)
where the control law of last time period, UN , is given by
UN = (GN
′AN+1GN +BN)
−1
GN
′AN+1(TN − I), (2.46)
and the result of minimization over βN is given by
J˜N = −αˆ′N |N P˜N+1αˆN |N , (2.47)
where
P˜N+1 = (TN − I)′AN+1GN(G′NAN+1GN +BN)−1G′NAN+1(TN − I). (2.48)
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Substitution of Eq. 2.47 into Eq. 2.43 yields
VN (℘N) =
(
αˆN |N − αˆN−1|N
)′
AN
(
αˆN |N − αˆN−1|N
)
+ αˆ′N |N
(
(TN − I)′AN+1(TN − I)− P˜N+1
)
αˆN |N
+ tr
[
AN
(
ΣˆN |N + ΣˆN−1|N − TN−1ΣˆN−1|N − ΣˆN−1|NTN−1′
)]
+ tr
[
AN+1
(
(TN − I)ΣˆN |N(TN − I)′
)]
+ tr [AN+1QN ] . (2.49)
Defining PN as follows,
PN = (TN − I)′AN+1(TN − I)− P˜N+1, (2.50)
and also replacing tr
[
AN+1
(
(TN − I)ΣˆN |N(TN − I)′
)]
by its simpler form as identi-
fied in Lemma II.9 in Appendix 2.7.2, we can further simplify Eq. 2.49 as follows.
VN (℘N) =
(
αˆN |N − αˆN−1|N
)′
AN
(
αˆN |N − αˆN−1|N
)
+ tr
[
AN ΣˆN |N
]
+ αˆ′N |NPN αˆN |N + tr
[
PN ΣˆN |N
]
+ tr
[
AN
(
ΣˆN−1|N − TN−1ΣˆN−1|N − ΣˆN−1|NTN−1′
)]
+ tr
[
P˜N+1ΣˆN |N
]
+ tr [AN+1QN ] . (2.51)
2.7.2 Lemmas
In the derivation of optimal control the following lemmas are needed.
Lemma II.4. For any symmetric n ∗ n matrix A, the following holds.
E [x′Ay] = x¯′Ay¯ + tr [AVx,y] . (2.52)
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Where
x¯ = E[x], (2.53)
y¯ = E[y], (2.54)
Vx,y = E [(x− x¯)(y − y¯)′] . (2.55)
Proof. By writing the matrix operations in terms of summations we will have
x′Ay =
n∑
i=1
n∑
j=1
xiAijyj. (2.56)
Hence
E [x′Ay] =
n∑
i=1
n∑
j=1
AijE[xiyj], (2.57)
but
E[xiyj] = E[xi]E[yj] + E [(xi − E[xi]) (yj − E[yj])] = x¯iy¯j + Vxi,yj . (2.58)
When Eq. 2.58 is substituted in Eq. 2.57:
E [x′Ay] = x¯′Ay¯ +
n∑
i=1
n∑
j=1
AijVxi,yj = x¯
′Ay¯ + tr [AVx,y] , (2.59)
where tr [M ] stands for trace of M (i.e., sum of diagonal terms).
Lemma II.5. With information up to time t, we have the following covariance rela-
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tions.
Cov(αt, αt+1|℘t) = Σˆt|tTt′, (2.60)
Cov(αt+1, αt|℘t) = TtΣˆt|t, (2.61)
Cov(αt, αt−1|℘t) = Tt−1Σˆt−1|t, (2.62)
Cov(αt−1, αt|℘t) = Σˆt−1|tTt−1′. (2.63)
Proof. Before we start proving these equations note that
Cov (αt, αt|℘t) = E [αtαt′]− E [αt]E[αt]′ → E [αtαt′] = Σˆt|t + αˆt|tαˆ′t|t. (2.64)
Therefore,
Cov(αt, αt+1|℘t) = E [αtαt+1′]− E [αt]E[αt+1]′
= E
[
αt(Ttαt +Gtβt + ηt)
′]− E [αt]E[Ttαt +Gtβt + ηt]′
= E [αtαt
′] Tt′ + αˆt|tβt
′Gt′ − αˆt|t
(
αˆ′t|tTt
′ + βt
′Gt′
)
=
(
Σˆt|t + αˆt|tαˆ′t|t
)
Tt
′ − αˆt|tαˆ′t|tTt′
= Σˆt|tTt′, (2.65)
and similarly
Cov(αt+1, αt|℘t) = TtΣˆt|t. (2.66)
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Furthermore,
Cov(αt, αt−1|℘t) = E [αtαt−1′]− E [αt]E[αt−1]′
= E [(Tt−1αt−1 +Gt−1βt−1 + ηt−1)αt−1′]
− E [Tt−1αt−1 +Gt−1βt−1 + ηt−1]E[αt−1]′
= Tt−1E [αt−1αt−1′] +Gt−1βt−1αˆ′t−1|t − Tt−1αˆt−1|tαˆ′t−1|t −Gt−1βt−1αˆ′t−1|t
= Tt−1
(
Σˆt−1|t + αˆt−1|tαˆ′t−1|t
)
− Tt−1αˆt−1|tαˆ′t−1|t
= Tt−1Σˆt−1|t, (2.67)
and similarly
Cov(αt−1, αt|℘t) = Σˆt−1|tTt−1′. (2.68)
Lemma II.6. With information up to time t, the expected quadratic penalty of disease
progression from period t− 1 to t can be calculated as follows.
E
[
(αt − αt−1)′At (αt − αt−1) |℘t
]
=
(
αˆt|t − αˆt−1|t
)′
At
(
αˆt|t − αˆt−1|t
)
+ tr
[
At
(
Σˆt|t + Σˆt−1|t − Tt−1Σˆt−1|t − Σˆt−1|tTt−1′
)]
.
(2.69)
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Proof. Using Lemma II.4 and Lemma II.5,
E
[
(αt − αt−1)′At (αt − αt−1) |℘t
]
= E [αt
′Atαt|℘t] + E [αt−1′Atαt−1|℘t]
− E [αt′Atαt−1|℘t]− E [αt−1′Atαt|℘t]
= αˆ′t|tAtαˆt|t + tr[AtΣˆt|t] + αˆ
′
t−1|tAtαˆt−1|t + tr[AtΣˆt−1|t]
− αˆ′t|tAtαˆt−1|t − tr[AtTt−1Σˆt−1|t]− αˆ′t−1|tAtαˆt|t − tr[AtΣˆt−1|tTt−1′]
=
(
αˆt|t − αˆt−1|t
)′
At
(
αˆt|t − αˆt−1|t
)
+ tr
[
At
(
Σˆt|t + Σˆt−1|t − Tt−1Σˆt−1|t − Σˆt−1|tTt−1′
)]
.
(2.70)
Lemma II.7. With information up to time t, the expected quadratic penalty of disease
progression from period t to t+ 1 can be calculated as follows.
E
[
(αt+1 − αt)′At+1 (αt+1 − αt) |℘t
]
= αˆ′t|t
(
(Tt − I)′At+1(Tt − I)
)
αˆt|t + βt
′(Gt′At+1Gt)βt + βt
′(Gt′At+1(Tt − I)αˆt|t)
+ (αˆ′t|t(Tt − I)′At+1Gt)βt + tr
[
At+1
(
(Tt − I)Σˆt|t(Tt − I)′ +Qt
)]
. (2.71)
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Proof. Using Eq. 2.1, Lemma II.4 and Lemma II.5,
E
[
(αt+1 − αt)′At+1 (αt+1 − αt) |℘t
]
= E [αt+1
′At+1αt+1|℘t] + E [αt′At+1αt|℘t]
− E [αt+1′At+1αt|℘t]− E [αt′At+1αt+1|℘t]
= (Ttαˆt|t +Gtβt)′At+1(Ttαˆt|t +Gtβt) + tr
[
At+1(TtΣˆt|tTt′ +Qt)
]
+ αˆ′t|tAt+1αˆt|t + tr[At+1Σˆt|t]
− (Ttαˆt|t +Gtβt)′At+1αˆt|t − tr
[
At+1TtΣˆt|t
]
− αˆ′t|tAt+1(Ttαˆt|t +Gtβt)− tr
[
At+1Σˆt|tTt′
]
= αˆ′t|t
(
(Tt − I)′At+1(Tt − I)
)
αˆt|t + βt
′(Gt′At+1Gt)βt + βt
′(Gt′At+1(Tt − I)αˆt|t)
+ (αˆ′t|t(Tt − I)′At+1Gt)βt + tr
[
At+1
(
(Tt − I)Σˆt|t(Tt − I)′ +Qt
)]
. (2.72)
Lemma II.8.
J˜N = min
βN
{βN ′(GN ′AN+1GN +BN)βN + βN ′(GN ′AN+1(TN − I)αˆN |N)
+ (αˆ′N |N(TN − I)′AN+1GN)βN} = −αˆ′N |N P˜N+1αˆN |N . (2.73)
Proof. The minimization over βN can be performed by completion of squares. For a
detailed discussion on how to take minimization by completion of squares please see
Section 3.3 of Sayed (2011). In here, we provide a short proof.
J˜N can be expressed in matrix form as follows.
J˜N = min
βN

[
1 βN
′
] 0 αˆ′N |N(TN − I)′AN+1GN
GN
′AN+1(TN − I)αˆN |N GN ′AN+1GN +BN

 1
βN

 .
(2.74)
The center matrix in 2.74 can be factored into a product of upper-triangular, diagonal,
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and lower-triangular matrices as follows.
J˜N = min
βN
{
[
1 βN
′
] 1 ωN ′
0 I

 −αˆ′N |N(TN − I)′AN+1GNωN 0
0 GN
′AN+1GN +BN

 1 0
ωN I

 1
βN
}, (2.75)
where
ωN = (GN
′AN+1GN +BN)
−1
GN
′AN+1(TN − I)αˆN |N . (2.76)
Expanding the right-hand-side of Eq. 2.75 yields
J˜N = min
βN
{−αˆ′N |N(TN − I)′AN+1GNωN + (βN + ωN)′ (GN ′AN+1GN +BN) (βN + ωN)} ,
(2.77)
in which only the second term depends on the unknown βN . Note that (GN
′AN+1GN+
BN) is positive semidefinite. This is because AN+1 and BN are diagonal cost matrices
with only positive terms on the main diagonal. So, the second term in Eq. 2.77 is
always nonnegative and will be minimized by choosing βN = −ωN .
Therefore, the optimum disease control β∗N and the result of minimization, i.e. J˜N ,
are given by the following equations respectively.
β∗N = −UN αˆN |N , (2.78)
where
UN = (GN
′AN+1GN +BN)
−1
GN
′AN+1(TN − I), (2.79)
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and
J˜N = −αˆ′N |N P˜N+1αˆN |N , (2.80)
where
P˜N+1 = (TN − I)′AN+1GN(G′NAN+1GN +BN)−1G′NAN+1(TN − I). (2.81)
Lemma II.9.
tr
[
AN+1
(
(TN − I)ΣˆN |N(TN − I)′
)]
= tr
[
PN ΣˆN |N
]
+ tr
[
P˜N+1ΣˆN |N
]
(2.82)
Proof. We know tr [XY ] = tr [Y X], tr [X (Y Z)] = tr [(XY )Z] and tr [(X + Y )Z] =
tr [XZ] + tr [Y Z]. Therefore,
tr
[
AN+1
(
(TN − I)ΣˆN |N(TN − I)′
)]
= tr
[
((TN − I)′AN+1(TN − I)) ΣˆN |N
]
(2.83)
From Eq. 2.50 we know (TN − I)′AN+1(TN − I) = PN + P˜N+1. Hence,
tr
[
((TN − I)′AN+1(TN − I)) ΣˆN |N
]
= tr
[(
PN + P˜N+1
)
ΣˆN |N
]
= tr
[
PN ΣˆN |N
]
+ tr
[
P˜N+1ΣˆN |N
]
(2.84)
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Lemma II.10.
E
zt+1
[
αˆ′t+1|t+1Pt+1αˆt+1|t+1|℘t
]
= (Ttαˆt|t +Gtβt)′Pt+1(Ttαˆt|t +Gtβt)
+ tr
[
Pt+1
(
TtΣˆt|tTt′ +Qt − Σˆt+1|t+1
)]
. (2.85)
Proof. From Lemma II.4 and Eq. 2.4
E
zt+1
[
αˆ′t+1|t+1Pt+1αˆt+1|t+1|℘t
]
= E
zt+1
[
αˆt+1|t+1|℘t
]′
Pt+1 E
zt+1
[
αˆt+1|t+1|℘t
]
+ tr
[
Pt+1 E
zt+1
[(
αˆt+1|t+1 − E
zt+1
[
αˆt+1|t+1|℘t
])(
αˆt+1|t+1 − E
zt+1
[
αˆt+1|t+1|℘t
])′]]
= (Ttαˆt|t +Gtβt)′Pt+1(Ttαˆt|t +Gtβt) + tr
[
Pt+1Kt+1 E
zt+1
[
y˜t+1y˜
′
t+1
]
Kt+1
′
]
, (2.86)
in which
E
zt+1
[
y˜t+1y˜
′
t+1
]
= E
zt+1
[(
zt+1 − Zt+1(Ttαˆt|t +Gtβt)
) (
zt+1 − Zt+1(Ttαˆt|t +Gtβt)
)′]
.
(2.87)
Replacing zt+1 by its value given by Eq. 2.2 yields
E
zt+1
[
y˜t+1y˜
′
t+1
]
= E
zt+1
[(
εt+1 + Zt+1(αt+1 − Ttαˆt|t −Gtβt)
) (
εt+1 + Zt+1(αt+1 − Ttαˆt|t −Gtβt)
)′]
= E
zt+1
[
(εt+1 + Zt+1(αt+1 − E[αt+1])) (εt+1 + Zt+1(αt+1 − E[αt+1]))′
]
= H
(θt+1)
t+1 + Zt+1
(
Tt
′Σˆt|tTt +Qt
)
Z ′t+1
= St+1. (2.88)
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Substitution of Eq. 2.88 into Eq. 2.86 results
E
zt+1
[
αˆ′t+1|t+1Pt+1αˆt+1|t+1|℘t
]
= (Ttαˆt|t +Gtβt)′Pt+1(Ttαˆt|t +Gtβt) + tr [Pt+1Kt+1St+1Kt+1′] .
(2.89)
Using Eq.’s 2.35, 2.7 - 2.9 yields
E
zt+1
[
αˆ′t+1|t+1Pt+1αˆt+1|t+1|℘t
]
= (Ttαˆt|t +Gtβt)′Pt+1(Ttαˆt|t +Gtβt)
+ tr
[
Pt+1
(
TtΣˆt|tTt′ +Qt − Σˆt+1|t+1
)]
. (2.90)
Lemma II.11.
E
zt+1
[(
αˆt+1|t+1 − αˆt|t+1
)′
At+1
(
αˆt+1|t+1 − αˆt|t+1
) |℘t]
=
(
(Tt − I)αˆt|t +Gtβt
)′
At+1
(
(Tt − I)αˆt|t +Gtβt
)
+ tr
[
At+1
(
TtΣˆt|tTt′ +Qt − Σˆt+1|t+1 − Σˆt+1|t+1Σˆ∗t ′ − Σˆ∗t Σˆt+1|t+1 + Σˆt|t+1
)]
.
(2.91)
Proof. This expectation can be divided into four parts as follows.
E
zt+1
[(
αˆt+1|t+1 − αˆt|t+1
)′
At+1
(
αˆt+1|t+1 − αˆt|t+1
) |℘t] = E
zt+1
[
αˆ′t+1|t+1At+1αˆt+1|t+1|℘t
]
− E
zt+1
[
αˆ′t+1|t+1At+1αˆt|t+1|℘t
]− E
zt+1
[
αˆ′t|t+1At+1αˆt+1|t+1|℘t
]
+ E
zt+1
[
αˆ′t|t+1At+1αˆt|t+1|℘t
]
.
(2.92)
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The first expectation in 2.92 is similar to the expectation of Lemma II.10. Therefore,
E
zt+1
[
αˆ′t+1|t+1At+1αˆt+1|t+1|℘t
]
= (Ttαˆt|t +Gtβt)′At+1(Ttαˆt|t +Gtβt)
+ tr
[
At+1
(
TtΣˆt|tTt′ +Qt − Σˆt+1|t+1
)]
. (2.93)
The second expectation in 2.92 can be simplified as follows.
E
zt+1
[
αˆ′t+1|t+1At+1αˆt|t+1|℘t
]
= E
zt+1
[
αˆt+1|t+1|℘t
]′
At+1 E
zt+1
[
αˆt|t+1|℘t
]
+ tr
[
At+1Cov
(
αˆt+1|t+1, αˆt|t+1
)]
= (Ttαˆt|t +Gtβt)′At+1αˆt|t + tr
[
At+1Cov
(
αˆt+1|t+1, αˆt|t+1
)]
,
(2.94)
in which
Cov
(
αˆt+1|t+1, αˆt|t+1|℘t
)
= E
[
αˆt+1|t+1αˆ′t|t+1|℘t
]− E [αˆt+1|t+1|℘t]E[αˆt|t+1|℘t]′
= E
[
αˆt+1|t+1
(
αˆt|t + Σˆ∗t (αˆt+1|t+1 − αˆt+1|t)
)′
|℘t
]
− E [αˆt+1|t+1|℘t] αˆ′t|t
= E
[
αˆt+1|t+1(αˆt+1|t+1 − αˆt+1|t)′|℘t
]
Σˆ∗′t
= E
[
αˆt+1|t+1αˆ′t+1|t+1|℘t
]
Σˆ∗′t − E
[
αˆt+1|t+1|℘t
]
(Ttαˆt|t +Gtβt)′Σˆ∗′t
= Σˆt+1|t+1Σˆ∗′t + (Ttαˆt|t +Gtβt)(Ttαˆt|t +Gtβt)
′Σˆ∗′t
− (Ttαˆt|t +Gtβt)(Ttαˆt|t +Gtβt)′Σˆ∗′t
= Σˆt+1|t+1Σˆ∗′t . (2.95)
Therefore,
E
zt+1
[
αˆ′t+1|t+1At+1αˆt|t+1|℘t
]
= (Ttαˆt|t +Gtβt)′At+1αˆt|t + tr
[
At+1Σˆt+1|t+1Σˆ∗t
′
]
. (2.96)
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In similar way, the third and fourth expectations in 2.92 can be simplified as follows.
E
zt+1
[
αˆ′t|t+1At+1αˆt+1|t+1|℘t
]
= αˆ′t|tAt+1(Ttαˆt|t +Gtβt) + tr
[
At+1Σˆ
∗
t Σˆt+1|t+1
]
, (2.97)
E
zt+1
[
αˆ′t|t+1At+1αˆt|t+1|℘t
]
= αˆ′t|tAt+1αˆt|t + tr
[
At+1Σˆt|t+1
]
. (2.98)
Replacing Eq.’s 2.93, 2.96, 2.97 and 2.98 into 2.92 yields
E
zt+1
[(
αˆt+1|t+1 − αˆt|t+1
)′
At+1
(
αˆt+1|t+1 − αˆt|t+1
) |℘t] = (Ttαˆt|t +Gtβt)′At+1(Ttαˆt|t +Gtβt)
+ tr
[
At+1
(
TtΣˆt|tTt′ +Qt − Σˆt+1|t+1
)]
− (Ttαˆt|t +Gtβt)′At+1αˆt|t − tr
[
At+1Σˆt+1|t+1Σˆ∗t
′
]
− αˆ′t|tAt+1(Ttαˆt|t +Gtβt)− tr
[
At+1Σˆ
∗
t Σˆt+1|t+1
]
+ αˆ′t|tAt+1αˆt|t + tr
[
At+1Σˆt|t+1
]
=
(
(Tt − I)αˆt|t +Gtβt
)′
At+1
(
(Tt − I)αˆt|t +Gtβt
)
+ tr
[
At+1
(
TtΣˆt|tTt′ +Qt − Σˆt+1|t+1 − Σˆt+1|t+1Σˆ∗t ′ − Σˆ∗t Σˆt+1|t+1 + Σˆt|t+1
)]
.
(2.99)
Lemma II.12.
tr
[
(At+1 + Pt+1)
(
TtΣˆt|tTt′
)]
= tr
[
PtΣˆt|t
]
+ tr
[(
P˜t+1 + At+1Tt + Tt
′At+1 − I
)
Σˆt|t
]
(2.100)
Proof. We know tr [XY ] = tr [Y X], tr [X (Y Z)] = tr [(XY )Z] and tr [(X + Y )Z] =
tr [XZ] + tr [Y Z]. Therefore,
tr
[
(At+1 + Pt+1)
(
TtΣˆt|tTt′
)]
= tr
[
(Tt
′ (At+1 + Pt+1)Tt) Σˆt|t
]
(2.101)
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Using Eq. 2.35 to replace Tt
′ (At+1 + Pt+1)Tt we have
tr
[
(Tt
′ (At+1 + Pt+1)Tt) Σˆt|t
]
= tr
[(
P˜t+1 + Pt + At+1Tt + Tt
′At+1 − I
)
Σˆt|t
]
= tr
[
PtΣˆt|t
]
+ tr
[(
P˜t+1 + At+1Tt + Tt
′At+1 − I
)
Σˆt|t
]
.
(2.102)
2.7.3 Results on Target IOP and MD Loss Averted
Since target IOP is an important metric that helps guide clinicians in selecting
the appropriate treatment plan for the patient, the distribution of target IOPs is
also of interest. Figure 2.9 shows the histogram of target IOPs for fast and slow-
progressing patients under the high and moderate aggressiveness policies. The range
and mean of each category is clinically appropriate in the professional opinion of our
glaucoma specialist collaborator. Figure 2.10 graphs the MD loss averted in [dB]
Figure 2.9: Histogram of target IOPs for CIGTS and AGIS patients under different
aggressiveness policies.
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for fast and slow-progressing patients under the high and moderate aggressiveness
policies compared against the low aggressiveness policy over 10 years of following the
IOP controls suggested by our model. As seen in the Figure, fast-progressing patients
will lose fewer MD points (i.e., experience better vision quality) resulting from further
lowering their eye pressure in short term, whether the doctor chooses moderate or
high aggressiveness level. Slow-progressors, if treated under the high aggressiveness
policy, could benefit from losing fewer MD points in the long term. However, this
group of glaucoma patients does not gain evident benefit from employing the moderate
aggressiveness policy even in the long term.
Figure 2.10: MD loss averted [dB] for fast and slow-progressing patients under the
high and moderate aggressiveness policies compared against the low ag-
gressiveness policy (i.e., no additional IOP reduction beyond those em-
ployed in trials) over 10 years of following the IOP control suggested by
our model. Period 1 is six months into the future; period 20 is 10 years
into the future.
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CHAPTER III
Healthcare Provider Shift Design to Minimize
Patient Handoffs
3.1 Introduction and Background
In November 1999, the U.S. Institute of Medicine (IOM) issued a report on medi-
cal errors estimating that nearly 100,000 patients die each year as a result of medical
errors and another 15 million are harmed (Kohn et al. 2000). Root cause analysis of
reported sentinel events from 1994 to 2004 revealed that two-thirds of these errors
were due to communication failures (Volpp and Grande 2003). According to Dr. Lu-
cien Leape, the number of deaths from medical errors in hospitals is equivalent to
the death toll from three jumbo jet crashes every two days (Leape et al. 1999). In
fact, more people die as a result of medical errors than from motor vehicle accidents,
breast cancer, or AIDS. Recent reports continue to support the initial findings from
IOM (Institute of Medicine, Committee on Quality of Health Care in America 2001)
and connect fatigue-related medical errors with residents’ duty hours (Ulmer et al.
2008).
In September 2010, the Accreditation Council for Graduate Medical Education (ACGME)
enacted new duty-hour regulations for residents and fellows (see Nasca et al. 2010)
that limited weekly work hours, length of duty periods, off time between shifts, and
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frequency of consecutive on-call days and nights. These stricter duty-hour require-
ments went into effect on July 1, 2011. The goal was to reduce fatigue-related medical
errors and improve patient safety by limiting residents/fellows (trainees) work hours.
However, the more restrictive shifts have resulted in a significant increase in patient
handoffs and communication failures (see Vidyarthi et al. 2006; Horwitz et al. 2006;
Philibert and Leach 2005; Horwitz et al. 2007; Hutter et al. 2006; Lockley et al. 2006).
Patient handoff is defined as “the process of transferring primary authority and re-
sponsibility for providing clinical care to a patient from one departing caregiver to
one oncoming caregiver” (Patterson and Wears 2010). Some other terms that have
commonly been used for handoff in the literature are handover, sign-out, turnover,
transition of care, transfer of care and shift change transfer. It is worth noting that
the working shifts of both residents and fellows must comply with the ACGME duty
hour regulations. For ease of reference, we use the term “trainees” to refer to both
residents and fellows in the rest of the chapter. We also refer to postgraduate year 2
(PGY-2) and above residents and all fellows as “senior trainees”.
Several studies have correlated increased patient handoffs with more medical errors
caused by communication breakdowns and therefore worse patient outcomes (see
Risser et al. 1999; Sutcliffe et al. 2004; Arora et al. 2007; Frankel et al. 2006; Jagsi
et al. 2005; Greenberg et al. 2007; Landrigan et al. 2004; Petersen et al. 1994; Li et al.
2011; Kitch et al. 2008; Gandhi 2005). It is believed that 20% - 30% of information
conveyed during patient handoffs is not documented in the medical record (see Sexton
et al. 2004; Risser et al. 1999). Figure 3.1 depicts the connection between the new
ACGME duty-hour regulations and medical errors.
Several studies have focused on the communication aspects of handoffs and have
provided recommendations to achieve high quality handoffs (see Ye et al. 2007; Arora
and Johnson 2006; Solet et al. 2005, 2004; Nemeth 2012; Arora et al. 2005, 2008; Hen-
riksen et al. 2008; Cheung et al. 2010; Donchin et al. 2003; Kemp et al. 2008). For
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Figure 3.1: Connection between ACGME standards and medical errors - the net effect
is uncertain.
example, Kemp et al. (2008) presented a methodology for conducting safe and effec-
tive sign-outs in a surgical service. Clark et al. (2011) designed a sign-out template to
standardize the handoff process in a general surgery residency program. Other studies
have focused on the overall handoff process. For instance, Abraham et al. (2012) pro-
posed a clinician-centered approach that captures the entire clinician workflow prior
to, during, and after handoff communication. Most of these studies have employed
interviews, surveys, and observations to understand handoff failures and provide sug-
gestions to enhance handoff fidelity.
While a high-quality, structured handoff process is important, decreasing number of
patient handoffs is an additional and fundamental way to reduce opportunities for
medical errors caused by communication breakdowns, supporting safer and more ef-
ficient patient care. The new ACGME duty-hour standards themselves specifically
emphasize the importance of reducing handoffs:
“Programs must design clinical assignments to minimize the number of transitions in
patient care.”
Borman et al. (2012) recently surveyed surgery residents and identified that resident
perceptions of causes of medical errors suggest that system changes are more likely to
enhance patient safety than further hour limits. This research provides mathemati-
cal methods for effecting such system change, by redesigning schedules to reduce the
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number of patient handoffs, hence reducing the opportunity for communication error.
While recent research has focused on improving the quality of communication during
the handoff process (i.e. improving box 6 in Figure 3.1) to reduce medical errors
caused by communication breakdowns, to the best of our knowledge, no prior work
leverages physician scheduling to reduce the quantity of handoffs (i.e. improving box
5 in Figure 3.1). This research contributes to the handoff literature by providing an
Integer Programming (IP) approach to design trainees’ schedules in a patient-centered
manner that minimizes number of handoffs while respecting ACGME duty-hour stan-
dards. The methodology we develop is highly generalizable and, while the proof of
concept is developed for an Intensive Care Unit (ICU), our approach can be ap-
plied to many different care units in hospitals, including different intensive care unit
types (e.g. Medical ICU, Surgical ICU, Pediatric ICU, Critical Care Unit, etc.), the
emergency department, and general floor care (internal medicine or surgery). This
approach can also be employed for different provider levels, e.g. attending physicians,
fellows, residents, nurses, etc.
Mathematical optimization techniques have been widely used to solve the physician
and nurse scheduling problems in a provider-centered manner (see Carter and Lapierre
2001; Ernst et al. 2004; Aickelin and Dowsland 2004; Gutjahr and Rauner 2007). In
the physician scheduling problem, given a set of doctors, a set of shifts and a planning
period, one seeks to find fair schedules for all physicians (Gendreau et al. 2006). In
the nurse scheduling problem, the cost of salaries should also be minimized.
Several studies have employed integer programming to formulate and solve the physi-
cian and nurse scheduling problems (see Gascon et al. 2000; Bard and Purnomo 2005;
Beaulieu et al. 2000; Sherali et al. 2002; Cohn et al. 2009). These studies provide
mathematical models to assign healthcare providers to pre-determined fixed shifts
(i.e. shift assignment models). Gascon et al. (2000) studied the flying squad nurse
scheduling problem. A multi-objective integer programming problem with binary
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variables was employed to find a feasible schedule satisfying most of the constraints.
The paper combined the sequential and the weighted method to obtain the best
nurse schedule for minimizing the deviation measures in soft constraints. Bard and
Purnomo (2005) developed an integer programming model to produce a revised sched-
ule for regular and pool nurses to efficiently use them in the event of surge in demand
for nursing services. The objective is to achieve sufficient coverage with the minimum
cost of revising nurses’ schedules. Beaulieu et al. (2000) addressed the problem of
physician scheduling. This paper employed integer programming to make a sched-
ule for physicians in the emergency room of a major hospital in Montreal, Canada.
The model was able to generate a better schedule with smaller deviations from de-
sired metrics in much shorter amount of time than the current method being used by
hospital staff. Sherali et al. (2002) proposed mixed-integer programming models to
address the resident scheduling problem concerned with prescribing work-nights for
residents. Heuristic solution approaches were developed to solve the problem under
different scenarios. Cohn et al. (2009) also combined IP-based techniques with user
expertise and heuristic approaches to construct high-quality schedules for residents
in the psychiatry program at Boston University School of Medicine based on their
individual preferences.
Our IP-based shift design and assignment model differs in that it simultaneously
(1) finds the best times for starting and ending the shifts to minimize the number
of patient handoffs (this is the shift design part), and (2) assigns physicians to the
shifts such that all ACGME duty-hour regulations are satisfied, required coverage is
achieved, and livability rules are met (this is the shift assignment part). The shift
design concept brings a new perspective to the problem of how best to incorporate the
ACGME rules and provides a systematic, model-driven method for designing physi-
cians’ schedules compared to the conventional approach of selecting between either
two 12-hour shifts or three 8-hour shifts per day. It further benefits patients by min-
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imizing error-contributing handoffs while maintaining physicians’ quality of life.
3.2 Model Development
In this section we present model assumptions, sets, parameters, variables, con-
straints and objective function. The parametric model in this section is based on
the ICU setting for scheduling trainees at the Mayo Clinic; however, the same model
(perhaps with slight modification) could be used for other hospital care units.
3.2.1 Assumptions
Because of the IP framework and also to ensure tractable and practical solutions,
it is necessary to divide each day into discrete time blocks and to assume that shift
change can happen only at the start/end of these time blocks. For example, if a day is
divided evenly into 6 time blocks, each block would be 4 hours and shift changes can
occur only at times 0, 4, 8, 12, 16 and 20. In other words, each physician can either
work or not work in a full time block. We also approximate the number of patients
handed off in each shift change based on historical data on ICU patient census by
time of day and day of week.
3.2.2 Sets and Parameters
We use the following sets in our model.
• I: set of trainees,
• J : set of days within the planning horizon,
• T : set of weeks within the planning horizon,
• K: set of time blocks within a day,
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• Kn: set of time blocks corresponding to night shift,
• Kr: set of time blocks that end during rounding time interval,
• Kinc: set of time blocks that end during inconvenient time interval for shift
change (usually considered as late night and early morning).
The main model parameters are listed below.
• NbF : number of trainees (fellows or residents),
• NbD: number of days within the planning horizon,
• NbW : number of weeks within the planning horizon,
• NbB: number of time blocks within a day,
• ShL: maximum shift length allowed in hours,
• cjk: approximate number of patient handoffs incurred by a shift change at the
end of time block k in day j, calculated based on the average number of patients
in the ICU at the time of shift change,
• djk: minimum number of trainees required to be on-call at time block k of day
j.
We also use a few auxiliary parameters in our model to simplify the notation. They
are directly calculated from the main parameters.
• BL = 24
NbB
: length of each time block in hours,
• BShL = ⌊ShL
BL
⌋
: maximum number of consecutive time blocks which do not
exceed ShL hours,
• B10 = d10/BLe: minimum number of consecutive time blocks which exceed 10
hours.
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3.2.3 Decision Variables
The following decision variables are used in the model.
• xijk: 1 if trainee i is assigned to time block k on day j, and 0 otherwise;
• yjk: 1 if there is a shift change at the end of time block k on day j, and 0
otherwise;
• zij: 1 if trainee i is totally off-duty on day j, and 0 otherwise;
• wij: 1 if trainee i works at night on day j, and 0 otherwise.
3.2.4 Constraints
The model constraints can be classified into three categories: (1) required and
(2) desirable constraints are associated with mandatory and optional scheduling rules
respectively, while (3) linkage constraints enforce model dynamics.
3.2.4.1 Required Constraints
Certain constraints are required by regulation or organizational policy. The first
five of these constraints are required by ACGME duty-hour regulations, while the
last two are required by organizational policy.
1. Duty periods of postgraduate year 1 (PGY-1) residents must not exceed 16
hours in duration; however, senior trainees may be scheduled to a maximum
of 24 hours of continuous duty. The following inequalities ensure that trainees
do not work shifts longer than ShL hours. ShL is the maximum shift length
allowed in hours so we use this value as an upper bound for shift length.
BShL+s∑
k=s
xijk ≤ ShL
BL
∀i ∈ I,∀j ∈ J,∀s ∈ {1, ..., (NbB −BShL)}, (3.1)
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NbB∑
k=s
xijk +
s−(NbB−BShL)∑
k=1
xi,j+1,k ≤ ShL
BL
∀i ∈ I,∀j ∈ {1, ..., NbD − 1},
∀s ∈ {(NbB −BShL) + 1, ..., NbB}.
(3.2)
If ShL = 24 (i.e. the maximum allowed shift length is 24 hours), inequality 3.1
is not needed and only inequality 3.2 is kept.
2. Weekly duty hours must not exceed 80 hours:
7t∑
j=7(t−1)+1
∑
k∈K
xijk ≤ 80
BL
∀i ∈ I,∀t ∈ T. (3.3)
3. Trainees must have a minimum of 10 hours free of duty between scheduled duty
periods:
xi,j,k − xi,j,k+1 + xi,j,k+s+2 ≤ 1 ∀i ∈ I,∀j ∈ J,∀k ∈ {1, ..., NbB −B10},
∀s ∈ {0, ..., B10 − 2}, (3.4)
xi,j,k − xi,j,k+1 + xi,j,k+s+1 ≤ 1 ∀i ∈ I,∀j ∈ J,
∀k ∈ {NbB −B10 + 1, ..., NbB − 1},
∀s ∈ {0, ..., (NbB − 1)− k}, (3.5)
xi,j,k − xi,j,k+1 + xi,j+1,s+1 ≤ 1 ∀i ∈ I,∀j ∈ {1, ..., NbD − 1},
∀k ∈ {NbB −B10 + 1, ..., NbB − 1},
∀s ∈ {0, ..., k − (NbB −B10 + 1)}, (3.6)
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xi,j,NbB − xi,j+1,1 + xi,j+1,s+2 ≤ 1 ∀i ∈ I,∀j ∈ {1, ..., NbD − 1},
∀s ∈ {0, ..., B10 − 2}. (3.7)
If NbB ≥ 3, inequalities 3.4 - 3.7 are required. Otherwise, this rule is automat-
ically satisfied by other required constraints and the above inequalities are not
needed to make sure trainees will get at least 10 hours off between shifts.
4. Trainees must get at least one day off per 7-day period (when averaged over 4
weeks):
7(t−1)+28∑
j=7(t−1)+1
zij ≥ 4 ∀i ∈ I,∀t ∈ {1, ..., NbW − 3}. (3.8)
5. Trainees must not be scheduled for more than 6 consecutive shifts of night duty
(night float):
6∑
s=0
wi,j+s ≤ 6 ∀i ∈ I,∀j ∈ {1, ..., NbD − 6}. (3.9)
6. The required coverage must be satisfied (coverage constraint):
∑
i∈I
xijk ≥ djk ∀j ∈ J,∀k ∈ K. (3.10)
7. Shift change is not allowed during bedside multi-disciplinary rounds because
this would disrupt the rounding process and impact the educational benefit to
trainees:
yjk = 0 ∀j ∈ J,∀k ∈ Kr. (3.11)
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3.2.4.2 Linkage Constraints
The following inequalities serve as linkage constraints to connect x, y, z and w
variables.
1. Inequalities 3.12 - 3.15 ensure that whenever there is a shift change at the end
of time block k on day j, variable yjk is assigned value 1.
yjk ≥ xijk − xi,j,k+1 ∀i ∈ I,∀j ∈ J,∀k ∈ {1, ..., NbB − 1}, (3.12)
yjk ≥ xi,j,k+1 − xijk ∀i ∈ I,∀j ∈ J,∀k ∈ {1, ..., NbB − 1}, (3.13)
yj,NbB ≥ xi,j,NbB − xi,j+1,1 ∀i ∈ I,∀j ∈ {1, ..., NbD − 1}, (3.14)
yj,NbB ≥ xi,j+1,1 − xi,j,NbB ∀i ∈ I,∀j ∈ {1, ..., NbD − 1}. (3.15)
2. The following inequality ensures that whenever zij is 1, trainee i is off-duty on
day j.
∑
k∈K
xijk ≤ NbB(1− zij) ∀i ∈ I,∀j ∈ J. (3.16)
3. Inequalities 3.17 and 3.18 ensure that wij is 1 when trainee i works at night on
day j, and 0 otherwise.
xijk ≤ wij ∀i ∈ I,∀j ∈ J,∀k ∈ Kn, (3.17)
wij ≤
∑
k∈Kn
xijk ∀i ∈ I,∀j ∈ J. (3.18)
3.2.4.3 Desired Constraints
In addition to the required constraints, there are some other characteristics for a
schedule which are not required, but are desirable to obtain more convenient and liv-
able schedules. These could include vacation requests, sleep hours, circadian rhythm
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or other human factors issues. In this part, we discuss the desired constraints in our
model. These rules have been developed through several meetings and discussions
with program directors, consultants, chief residents and fellows at Mayo Clinic.
1. To maintain regular sleep hours for trainees, we disallow shift changes at late
night or early morning (inconvenient times).
yjk = 0 ∀j ∈ J,∀k ∈ Kinc. (3.19)
2. ACGME rules only require one day off per 7-day period (when averaged over 4
weeks). However, working several days in a row could cause fatigue, irritability
and reduced concentration for trainees. Hence, the desire is to provide at least
one day off per any 7-day period (without averaging). This means that, trainees
are permitted to work no more than six days in a row.
6∑
s=0
zi,j+s ≥ 1 ∀i ∈ I,∀j ∈ {1, ..., NbD − 6}. (3.20)
3. Based on ACGME regulations, trainees are allowed to be on call for up to six
consecutive night shifts. Nevertheless, it is believed that doing a lengthy run
of night shifts might be associated with extreme fatigue, insomnia, and sleep
deprivation. Hence, we limit the night float to a maximum of four consecutive
night shifts.
4∑
s=0
wi,j+s ≤ 4 ∀i ∈ I,∀j ∈ {1, ..., NbD − 4}. (3.21)
4. The minimum required off-time between scheduled duty periods is considered
as 10 hours by ACGME. However, switching to day time work after doing a run
of night shifts is hard for human brain. Preferably, trainees would have at least
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Table 3.1: Scheduling constraints: required constraints (RC) and desired constraints
(DC).
one whole day off (in addition to the post-call day) after doing a run of night
shifts to better adjust their sleep pattern. The following inequality ensures that
after each night shift, either another night shift or a day off should be assigned
to trainees.
wij − wi,j+1 − zi,j+1 ≤ 0 ∀i ∈ I,∀j ∈ {1, ..., NbD − 1}. (3.22)
5. Although ACGME duty hour regulations allow a shift to last up to 16 hours
for PGY-1 and 24 hours for PGY-2 and above, shifts longer than 12 hours
are believed to be associated with fatigue, headaches, irritability and reduced
concentration. Hence, we limit the shift length to 12 hours by setting the value
of ShL parameter to 12 in inequalities 3.1 and 3.2.
To summarize our discussion in this section, all the Required Constraints (RCs) and
Desired Constraints (DCs) are listed in Table 3.1.
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3.2.5 Objective Function
The objective is to minimize the approximate number of patient handoffs during
the scheduling horizon, calculated based on the average ICU patient census at the
time of shift change. Figure 3.2 provides two examples of how the number of patient
handoffs is affected by the number of patients in the ICU. In Fig. 3.2(a), there are
two shift changes (provider transfers) at 7 am/pm. At the 7 am shift change there
are two patients in ICU, so we incur two handoffs, while at 7 pm there is one patient
in ICU and we incur one handoff. Fig. 3.2(b) illustrates the same scenario, but with
only one shift change at noon, where 4 patients are handed off. Clearly, minimizing
number of patient handoffs is not equivalent to minimizing number of shift changes.
Furthermore, longer shifts do not guarantee fewer handoffs as seen in the example
of Figure 3.2 (which also illustrates how the number of handoffs is calculated in our
model). The challenge lies in designing a schedule that complies with all required
constraints (and preferably most desired constraints) in a way that fewer patients
have to be handed off. The objective function can be written as follows:
min
∑
j∈J
∑
k∈K
cjkyjk. (3.23)
3.3 Case Study
This section presents a detailed discussion of how our model can be applied in a
healthcare setting to help redesign trainees’ on-call shifts to minimize the number of
patient handoffs. We applied our model to the Medical Intensive Care Unit (MICU) at
Saint Marys hospital in Rochester, Minnesota operated by Mayo Clinic. The MICU
at Saint Marys hospital is a 24-bed unit. Our focus is on redesigning the fellows’
shifts, as their service has the most impact on patient outcomes. Similar analysis can
be applied to other provider levels (e.g., residents, attending consultants, etc.) and
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Figure 3.2: Examples of how the number of patient handoffs is calculated in the
performance analysis model: (a) 2 shift changes and 3 patient handoffs,
(b) 1 shift change and 4 patient handoffs.
other hospital units as well.
3.3.1 Assumptions
The detailed parameterization of the model for the case study was obtained
through several meetings with residency and fellowship program directors, chief resi-
dents and fellows, as well as feedback from different medical providers at Mayo Clinic.
For the case study, we consider a 4-week scheduling horizon which starts on a Satur-
day and ends on a Friday as trainees at Mayo Clinic rotate between different units
every four weeks. Two years of MICU admission and discharge data were used to
calculate the approximate MICU census for different days of week and times of day.
Each day was divided into 12 time blocks. Hence, shift changes can happen at any
of times 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20 and 22 in military time format. One nice
property of the 2-hour time block is that, for this case study, the resulting schedule
has a symmetric structure. The symmetric structure of our proposed schedule makes
it easy to remember and much more appealing for implementation.
Based on ACGME rules, the maximum shift length is 16 hours for postgraduate year
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1 (PGY-1) residents and 24 hours for senior trainees. Because the 24-hour shifts
are believed to cause extreme tiredness and sleep deprivation contributing to more
fatigue-related medical errors and poor patient outcomes, we limit the maximum shift
length to 16 hours for fellows. Currently fellows work 12-hour shifts in the MICU. We
start our analysis with a 16-hour limit on shift length, but will perform a sensitivity
analysis on shorter and longer shifts later.
Some constraints deal with night shifts. In our study, we define night to be from
10:00 pm to 6:00 am. Hence, if a fellow is on call at any time in this interval, we
assume he/she is on a night shift.
To provide 24/7 coverage, at least three fellows are required. This is because each
fellow can work a maximum of 80 hours per week and we want to provide 24∗7 = 168
hours weekly coverage. Hence, we need at least
⌈
168
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⌉
= 3 fellows.
For inequality 3.11, which ensures there is no shift change during the bedside multi-
disciplinary rounds, we need to determine the set of time blocks that end during this
interval. Currently, the bedside rounds happen from 8:30 am to 11:00 am in the
MICU.
Finally, a shift change is not allowed at inconvenient times (late night and early morn-
ing) through inequality 3.19. In this case study, we assume any time after 10:00 pm
and before 4:00 am is inconvenient for a shift change.
3.3.2 Set and Parameter Values
Based on our previous discussion, model sets and parameters are assigned the
following values.
Sets:
• I = {1, 2, 3},
• J = {1, 2, ..., 28},
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• T = {1, 2, 3, 4},
• K = {1, 2, ..., 12},
• Kn = {1, 2, 3, 12},
• Kr = {5},
• Kinc = {1, 2, 12}.
Parameters:
• NbF = 3,
• NbD = 28,
• NbW = 4,
• NbB = 12,
• ShL is equal to 12 if DC5 is included in the scenario under consideration, and
16 otherwise,
• djk =

1 . . . 1
...
. . .
...
1 · · · 1

28∗12
,
• BL = 24
NbB
= 2,
• BShL = ⌊ShL
BL
⌋
= 8,
• B10 = d10/BLe = 5,
• cjk is equal to the average MICU patient census at the end of time block k in
day j.
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3.3.3 Data Collection
We used two years of MICU admission and discharge data to obtain patient census
profiled by time of day and day of week. A computer program was developed to
extract the required data from the dataset and to keep track of patient admissions
and discharges for each time block of every day. Figure 3.3 shows the average MICU
admission and discharge patterns during the day. As seen in this graph, there are
almost no discharges at nights. Bedside rounds start at 8:30 am during which the
discharge decisions are made by the team of residents, fellows and consultants. Patient
discharges typically start around 9:00 am. The admission process is smoother with
a higher average during the daytime. Figures 3.4 and 3.5 show the average MICU
patient census versus different times of day and days of week. Mornings are more
crowded than evenings since there is no discharge from the MICU at nights and
before the rounds start in the morning. These results make sense intuitively and are
in line with expert opinion which supports our data collection. Although the MICU
census fluctuates from month to month, the pattern for different times of day and
different days of week is similar. Since the census pattern is what matters for our
shift design study (rather than the actual census numbers), we take the grand average
census over months of year and use these numbers to approximate number of patient
handoffs in our data-driven numerical analysis.
3.3.4 Experimental Scenarios
In this section, we solve the scheduling problem for different combinations of con-
straints to determine their effect on the objective function. The intent is to determine
which desired constraints have the most impact on the number of patient handoffs.
As discussed before, required constraints are those constraints that must be enforced
in order to obtain valid or feasible schedules. Desired constraints are not required
to be satisfied, but they make the resulting schedule more appealing. We perform
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Figure 3.3: MICU admissions and discharges.
our analysis by adding one or a combination of desired constraints to the model and
study their impact on the objective value (number of patient handoffs). If a desired
constraint results in a great increase in the number of patient handoffs, loosening its
bound or removing it will help avoid an increase in handoffs. This provides insight
into the relative cost in terms of handoffs of a desired constraint.
There are 32 combinations of the five desired constraints. Those include having no
desired constraints satisfied (1 case), having one desired constraint satisfied (5 cases),
and so on. We will show the approximate number of patient handoffs for each case
later in this section. First, we start with two extreme cases.
Scenario A - Only Required Constraints: The first scenario we investigate is the case
in which only required constraints are satisfied. The resulting schedule will provide a
lower bound on the minimum achievable number of handoffs. The number of patient
handoffs from this case is used as the baseline for our comparison. The solution yields
635 patient handoffs over the 4-week scheduling horizon.
Scenario B - All Required Constraints and All Desired Constraints: The second sce-
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Figure 3.4: Average MICU patient census vs. time of day.
nario we study is the case in which all required and desired constraints are satisfied.
This provides an upper bound on the number of patient handoffs. Interestingly, the
resulting schedule was the same as current MICU schedule with 831 patients handed
off during the 4-week horizon. The cost of having all desired constraints satisfied is a
31% increase in the number of patient handoffs.
Scenario C - All Required Constraints Together With One Desired Constraint: The
previous scenarios provide a lower and an upper bound for the number of patient
handoffs (635 and 831 respectively). In this scenario, we study the impact of each
desired constraint on the number of patient handoffs by including them in the model
individually. Scenarios C1, C2, C3, C4 and C5 are related to the cases in which DC1,
DC2, DC3, DC4 and DC5 are added to the model respectively. The results show that
adding DC2 or DC4 does not increase the number of patient handoffs, while adding
DC1 or DC3 results in 641 patient handoffs (1% increase). On the other hand, adding
DC5 (limiting shift length to 12 hours) results in 831 patient handoffs, the same result
as the upper bound.
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Figure 3.5: Average MICU patient census vs. day of week.
Scenario D - All Required Constraints Together With DC1-DC4: The results of previ-
ous scenarios revealed that each of these constraints individually does not significantly
degrade the objective function. Including all of them simultaneously leads to a sched-
ule with 641 patient handoffs on average over the 4-week horizon. This is only 1%
greater than the lower bound (Scenario A), which includes none of the desired con-
straints.
Scenario E - All Required Constraints Together With DC2 and DC4: In scenario C,
we saw that adding DC2 or DC4 to the model one at a time would not increase the
number of patient handoffs. In this scenario, we investigate the effect of having both
of them satisfied. The solution results in 641 handoffs, exactly the same as scenario
D where DC1-DC4 are satisfied. Consequently, scenario E is dominated by scenario
D.
Table 3.2 summarizes the results in this section. It shows all cases together with the
scenarios we discussed in this section, the number of patient handoffs for each case,
and whether each case is efficient or not. Those cases that are not dominated by any
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other case are efficient schedules.
As seen in Table 3.2, scenarios B, C2, C4 and D are efficient schedules. However,
from a practical standpoint, scenario D is preferred to scenarios C2 and C4, since DC1
- DC4 are satisfied with only 1% increase in the number of patient handoffs. Hence,
from practical standpoint, only scenarios B and D are efficient schedules. The only
difference between these two schedules is the limit on shift length. Figure 3.6 shows
the resulting schedules corresponding to scenarios B and D (12 hours and 16 hours
shift length limit, respectively).
Fellows at the Mayo MICU are currently working 12-hour shifts with shift changes
happening at 6 am and 6 pm. Our analysis in this part showed that the current
on-call schedule for fellows at Mayo’s MICU is indeed optimal if we want to maintain
12-hour shifts; however, the 16-hour shift length of scenario D is very attractive due
to the large number of handoffs saved (190 or 23% fewer).
Figure 3.6: Resulting schedules with (a) 12 hours per scenario B and (b) Scenario D
with 16 hours shift length limit. Each number and color refers to one of
the three fellows who is assigned to the corresponding time block.
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Table 3.2: Summary of results of experimental scenarios.
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3.3.5 Sensitivity Analysis and Discussion
In this section, we briefly review the main results from the previous section and
then provide further analysis of the shift length constraint.
The previous section showed that most of the desired constraints can be accommo-
dated without significantly increasing the number of patient handoffs. Those con-
straints include: no shift change at late night or early morning, at least one day off
every seven days, no more than four night shifts in a row and a minimum one day
off after a run of night shifts. The desired constraint that restricts shift length to 12
hours, however, increases the number of patient handoffs by more than 30%.
Based on ACGME duty-hour regulations, on-call shifts of residents in PGY-1 must
not exceed 16 hours while senior trainees (PGY-2 and above residents and all fellows)
may be scheduled for a maximum of 24 hours of continuous duty. To explore the
effect of shift length, we run the model for different shift lengths from 12 hours to
24 hours (in 2-hour increments). We keep all other required and desired constraints
active and only change the shift length bound (ShL parameter). Figure 3.7 shows
the resulting change in number of patient handoffs.
As seen in Figure 3.7, increasing shift length limit results in fewer patient hand-
offs. The current 12-hour shifts in Mayo MICU cause an average of 831 patients to
be handed off per month. Should the shift length be extended to 16 hours, this will
result in nearly a 23% reduction in number of patient handoffs per month. Increasing
the shift length to its maximum allowed limit, i.e. 24 hours, results in almost a 48%
reduction in number of patient handoffs per month. On one hand, shorter shifts cor-
relate with more frequent patient handoffs, which potentially results in more medical
errors due to communication breakdown and loss of information during the handoff
process. On the other hand, longer shifts are associated with extreme tiredness and
sleep deprivation which can also contribute to fatigue-related medical errors.
A reasonable tradeoff between fatigue and handoffs should be established to mini-
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Figure 3.7: Number of patient handoffs for different shift length limits.
mize medical errors and achieve the best patient outcomes. However, to date there
is no solid methodology to quantify physicians’ fatigue and the effect of fatigue on
quality of care and patient outcomes. The best we could do was to collect expert
opinions. Several program directors and physicians that we have interviewed believe
that 24-hour shifts are acceptable and worth the benefit of fewer patient handoffs. A
majority of program directors, chief residents and fellows believe 16-hour shifts are
very reasonable and worth the benefit of the 20%-25% reduction in patient handoffs
(compared to 12-hour shifts). The 16-hour shift length limit is permitted by ACGME
and could be applied to different trainee levels (i.e. PGY-1 residents, senior (PGY-2
and above) residents, and fellows). This appears to provide a good tradeoff between
the adverse effects of physicians’ fatigue and the adverse effects of more frequent pa-
tient handoffs.
One final point is the importance of maintaining fairness and balance among the
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trainees’ schedules. While this is not a mandated requirement, it is clearly important
for implementation and trainee morale. Therefore, we added measures and associated
constraints to ensure balance among the schedules for average duty hours, number
of night shifts, and the number of days off. Figure 3.8 shows the resulting equitable
schedule and associated fairness values that yields the same 641 patient handoffs
(with the shift length limit set at 16 hours).
Figure 3.8: Equitable schedule with all required and desired constraints and 16-hour
shift length limits.
3.4 Conclusions
In this chapter, we developed a new patient-centered model for scheduling resi-
dents and fellows (trainees) to minimize number of patient handoffs, which have been
linked with medical errors caused by communication breakdowns and adverse events.
While previous literature focuses on the logistics of the handoff, we bring a new sys-
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tems perspective to this problem by designing schedules that minimize the number of
patients that are handed off, thereby reducing the opportunity for serious error. Our
integer programming model designs on-call shifts such that all ACGME duty-hour
regulations are satisfied, required coverage is achieved, livability rules are met, and
patient handoffs are minimized. The general form of our model can be used by any
healthcare operation that wants to reduce patient handoffs and that has duty-hour
restrictions and similar livability constraints. Should the size of the model render
the problem intractable for other healthcare units, heuristics approaches such as the
Tabu Search and Ant Colony Optimization can be employed to solve the integer pro-
gram (see, for example, Balas and Martin 1980; Azadeh et al. 2013; Lokketangen and
Glover 1998).
In a case study of an ICU at an academic medical center (the Mayo Clinic in
Rochester, Minnesota) we demonstrated how our model could be applied to reduce
the number of patient handoffs. We found that most desired constraints (livability
rules) can be satisfied with a negligible increase in number of patient handoffs. The
desired constraint that had the largest impact on handoffs was the shift length. By
increasing the shift length from 12 to 16 hours it was possible to reduce handoffs by
23% relative to the current MICU schedule. 24-hour shifts (the maximum allowable
shift length) resulted in a 48% reduction in the number of patient handoffs. It is
worth noting that in the proposed schedule no new trainees (fellow for the case study
of Mayo MICU) need to be added beyond the minimum number needed to provide
the required coverage specified by the 10th required constraint (require coverage is
24/7 for the case study). Therefore, in terms of financial costs, the as-is schedule and
the proposed schedules are exactly the same.
Based on discussions with staff at Mayo Clinic, we found that 16-hour shifts provided
a reasonable tradeoff between medical errors due to trainee fatigue and medical errors
due to communication breakdowns as a result of more frequent patient handoffs. The
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new shift design approach discussed in this chapter is under consideration for imple-
mentation at Mayo Clinic. A shift assignment approach based on the work discussed
in this chapter was accepted by the practice and additional services are considering
the use of the general methodology to assist in staff scheduling at Mayo Clinic.
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CHAPTER IV
Coordinating Clinic and Surgery Appointments to
Meet Access Delay Service Level for Elective
Surgery
4.1 Introduction
The United States healthcare is facing a significant challenge in providing timely
access to care (Davis et al. 2014), which not only affects patient satisfaction but also
directly influences patient safety and health outcomes (Murray and Berwick 2003;
Koopmanschap et al. 2005). Long wait times may also result in elevated healthcare
costs because of additional treatments (Somasekar et al. 2002; Hilkhuysen et al. 2005).
To ensure patients can get medical care when they need it, it is critical to make effi-
cient use of the current healthcare resources to minimize access delay, which can lead
to a healthier society.
In this paper, we leverage systems engineering and operations research to improve
access to elective surgery in a highly specialized surgical unit. Our research is mo-
tivated by the issue of long waiting times for patients who need a surgery in the
colorectal surgery (CRS) department at the Mayo Clinic in Rochester, MN. In CRS,
like many surgical units across the country, the increase of patient demand is outpac-
ing the growth of surgical capacity, leading to long wait times. We define wait time
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as the number of business days between the day a patient is referred to CRS and the
day he or she is operated in the operating room (OR). Previous research indicates
that ineffective scheduling regimes are among the main factors contributing to un-
derutilization of ORs (see Weinbroum et al. 2003; Jonnalagadda et al. 2005). In this
paper, we propose and evaluate 6 carefully chosen scheduling policies that work better
than the current scheduling protocol. The underlying idea behind these scheduling
protocols is to efficiently use patient information to integrate and coordinate clinic
and surgery appointment scheduling such that patients can get a clinic visit and a
surgery appointment within a time period that is clinically safe for them while the
OR overtime is minimized.
4.2 Problem Description
CRS at the Mayo Clinic includes 8 surgeons. They form 2 teams of orange and
blue each consists of 4 surgeons. On any given day, one team sees patients in the clinic
and the other team is operating in the OR. The teams switch places on the following
business day. Therefore, each surgeon has a clinical and a surgical calendar. CRS
receives patient appointment requests from two separate channels: (1) the surgeon’s
desk (internal referrals), and (2) the direct clinic (external referrals). About 75%
of the requests come through the surgeon’s desk, which are usually referred by the
gastrointestinal (GI) department at the Mayo Clinic. The remaining 25% are referred
from other hospitals. Each new request needs a clinic appointment with a CRS
surgeon. The clinic visit may need to be followed by a surgery. Recently, CRS has
experienced an increase in the earliest surgery time they can offer to their patients.
The chief surgeon is worried that the long wait times can lead to adverse events and
poor patient outcomes especially for the urgent patients (e.g. colon cancer patients).
Figure 4.1 shows the two appointment request channels.
Current scheduling policy: Presently, the scheduling protocol/policy at CRS is
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Figure 4.1: CRS appointment request diagram.
focused strictly on finding the surgeon with the first available clinic slot and schedul-
ing a clinic visit for the patient with that surgeon. During the clinic visit, it is
determined whether or not surgery is required and the details concerning surgery. If
it is determined that the patient needs a surgery, the surgeon then looks into his/her
surgical calendar and offers the earliest date he/she can perform the surgery.
The above protocol now used in practice often results in a long wait time for urgent
patients to obtain surgery, because it waits until the day of the clinic visit to reserve
a date for surgery. A common scenario that motivated this research is as follows. A
cancer patient is assigned to surgeon X based on the clinical availability of surgeons.
When surgeon X sees the patient in the clinic, the surgeon and the patient jointly
determine to proceed with surgery. The surgery should be performed as soon as pos-
sible to prevent the tumor from further growing. Surgeon X looks into his surgical
calendar and finds out that his next surgical availability is 3 weeks into the future;
but, one of his colleagues, say surgeon Y, has surgical availability in 4 days. Surgeon
X asks the patient if he/she prefers to wait 3 weeks or be operated by surgeon Y. The
patient almost always prefers to wait and get the surgery with the same surgeon that
they got to know during the clinic visit rather than a colleague they have never met.
This is because the patient has already established some trust and a relationship with
surgeon X. Therefore, in this paper we assume that the surgery must be performed
by the same surgeon who has seen the patient in clinic.
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4.3 Literature Review
Appointment scheduling has been a topic of interest for many researchers over
the past few decades. Gupta and Denton (2008) provide a literature survey on ap-
pointment scheduling systems in 3 different healthcare settings: (1) primary care, (2)
specialty clinic, and (3) elective surgery. They describe the goal of a well-designed
appointment system as delivering timely access to health services for all patients.
This is in line with our main objective in this paper. Gupta and Denton (2008) also
indicate that most of the previous research has focused on minimizing the direct wait
time, which is the time from the moment patient enters the clinic to the time he/she
sees the doctor. Our focus in this research is to reduce the indirect wait time, which
corresponds to the number of days from the day of appointment request until the day
of appointment itself.
Two closely related papers to our work are Patrick et al. (2008) and Saure et al.
(2012). Patrick et al. (2008) present a Markov decision process (MDP) model with
rolling horizon to dynamically allocate the available capacity of a diagnostic resource
(CT scanner) between different patient priority classes. Each patient requires one
appointment slot. Surge capacity is diverted or delayed. Their objective is to min-
imize the number of patients who does not get an appointment by their maximum
wait time target. They solve the equivalent linear program through approximate
dynamic programming (ADP) to mitigate the curse of dimensionality of the MDP
model. Saure et al. (2012) develop an MDP-based modeling framework to allocate
available treatment capacity to incoming demand for scheduling cancer treatments in
radiation therapy units while reducing wait times. They consider multiple identical
radiation therapy machines and determine the total capacity by aggregating the in-
dividual capacities of machines. Each patient visit triggers a sequence of visits with
different number of appointment slots for each visit. Surge capacity is delayed or
accommodated using overtime. They use an ADP approach similar to Patrick et al.
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(2008) in order to solve the model. There are a number of differences between these
papers and our work. First, we consider multiple non-identical surgeons as scarce
resources and directly book appointments with them considering the individual ca-
pacities as opposed to considering one single resource or multiple identical resources
and aggregating the individual capacities. Second, they consider off-line scheduling
in which the scheduling decisions are made once a day; whereas, we consider online
scheduling in which the orders are scheduled one by one as they arrive to CRS. Third,
they consider that each new request requires either one or multiple visits and each
visit requires either one or multiple appointment slots; but, these are all assumed to
be known at the time the request is received. However, in our problem, each request
requires a clinic appointment and may or may not be followed by a surgery. The
uncertainty about needing a surgery is realized during the patient’s clinic visit. If it
is deemed that the patient does need a surgery, the actual surgery duration is not
realized until after the surgery is done, but can be estimated beforehand using his-
torical data.
Gupta and Wang (2008) develop a model to decide whether to accept or reject an
appointment request to maximize revenue while incorporating the patients’ prefer-
ences in terms of which doctor to see and the time of appointment into their decision
making. Wang and Gupta (2011) present a novel decision support tool that dynam-
ically learns and updates patients’ preferences and use this information to improve
booking decisions. Liu et al. (2010) propose heuristic dynamic policies for scheduling
patient appointments considering no-shows and cancelations and evaluate them using
computer simulation. In this paper, we do not consider patient no-shows and cance-
lations as they rarely happen in a highly-specialized care unit like colorectal surgery.
We also do not honor patients’ surgeon preference per recommendation of the chief
CRS surgeon. Clearly, in many healthcare environments, the patient can prioritize
the selection of the provider with whom they feel most comfortable. Our scope is,
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however, limited to the important class of environments in which the patients typi-
cally accept the surgeon offering the earliest access. It should be noted that it is not
too difficult to manually intervene in cases in which the algorithmic solution needs to
be tweaked to account for the occasional patient with strong provider preferences, if
they are willing to accept the potential delay.
Many researchers have used computer simulation to study appointment and/or surgery
scheduling and to test the performance of heuristic scheduling rules (Erdogan and
Denton 2011). Simulation is a powerful tool for assessing the potential response of a
health system to policy changes (Fone et al. 2003). For instance, Ho and Lau (1992)
study the performance of over 50 scheduling rules using simulation and conclude
that their performances are affected by the environmental conditions of the operating
environment. Vasilakis et al. (2007) develop a discrete event simulation model to com-
pare two methods of scheduling outpatient clinic appointments (individual surgeon
vs. pooled lists) in terms of number of patients waiting for appointments and wait
times to appointment and surgery. LaGanga and Lawrence (2007) leverage discrete
event simulation to investigate appointment over-booking as one means of reducing
the negative impact of no-shows and conclude that over-booking can improve patient
access, provider productivity, and overall clinic performance. Everett (2002), Gul
et al. (2011), Berg et al. (2014), Liang et al. (2015), and Zhang and Xie (2015) have
also used computer simulation to study appointment/surgery scheduling. The most
important difference between our work and the previous papers mentioned is that
we expand our view to proactively coordinate the scheduling of clinic and surgery
appointments such that patients with different levels of urgency can be served within
their maximum wait time target windows with minimum OR overtime. The concept
of coordinating clinic and surgery appointments is unique and novel in our work and
has never been studied before in the context of surgery scheduling and planning.
Unlike some surgical scheduling papers, our paper does not strive to determine how
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many ORs to open on each day and how to allocate the available OR time to the sur-
geons. In other words, we assume each surgeon has rigidly allocated block time. We
also do not specify the start time and the sequence of surgeries listed to be performed
on each day. Our model is concerned with determining (1) a clinic appointment day,
(2) a tentative surgery day, and (3) a surgeon to assign to both the clinic and the
surgery appointments for each new patient referred to CRS.
4.4 Solution Approach
In this section, we describe our solution approach to the problem of long wait
time to surgery in Mayo CRS that was described in Section 4.2. We tentatively
book/reserve a surgery day for all patients at the same time we are scheduling the
patient’s clinic appointment. In other words, instead of waiting until the patient’s
clinic appointment to figure out if they need a surgery and then try to book a surgery
day if they need one, we proactively schedule a tentative surgery day together with
a clinic appointment when the patient referral is received by CRS. This guarantees
timely access to surgery for all patients.
4.4.1 Data
We use 5-year historical data (2011 to 2015) on the CRS clinic and surgery ap-
pointments to perform our analysis. This includes data on about 12,000 patients.
When CRS receives a new appointment request (either through the surgeon’s desk or
the direct clinic), the following patient information are among the available data:
1. indication (i.e., colon cancer, anal cancer, rectal cancer, Crohn’s disease, chronic
ulcerative colitis, diverticulitis, neoplasi/polyp, rectal prolapse, slow transit con-
stipation, hernia, ostomy, or CRS other),
2. geographical location (i.e., local, regional, or national/international),
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3. age
4. referral type (i.e., internal or external),
5. estimated surgery duration (predicted from historical surgery duration data).
In addition to the above data, we have the actual surgery durations for cases that
have resulted in a surgery.
As mentioned in Section 4.2, on any given day, there are 4 surgeons in the OR and
4 in the clinic. On average, 2 of the surgeons get two ORs and 2 of them get one
OR. Those surgeons who get two ORs can schedule parallel-staggered surgeries and
let their team do the preparation, cutting, and closing of the patient. In this paper,
we assume surgeons with one OR and those with two or more ORs can schedule 8
and 12 hours of surgery per day, respectively. Per the recommendation of our clinical
collaborators, we also assume no limit for the clinical capacity of the surgeons. This
is because the clinic visits are relatively short (each clinic visit takes only 15 to 30
minutes); so, they are never the bottleneck and can be accommodated easily. Further,
the surgeons are willing to use clinic overtime to see a patient in clinic if it benefits
OR utilization and patient outcomes.
4.4.2 Patient Priority Levels/Types
Mullen (2003) and MacCormick et al. (2003) provide a comprehensive survey on
prioritizing patients in a waiting list. One common way to do so is based on the
patients’ acuity of disease. In this research, we use expert opinion to label each
patient as either priority type 1, 2, 3, 4, or 5 based on a combination of (1) the
indication of the patient, (2) the geographical zone, and (3) the referral type. Type
1 is for the most urgent cases, while on the other extreme, type type 5 is assigned to
patients who only need a clinic appointment for follow-up/consult or those who don’t
need a surgery in near future. Each priority type corresponds to a maximum wait
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time target (MWTT) to surgery, except that type 5 that does not require a surgery.
MWTT is the maximum time that the patient’s surgery can be safely delayed. We
determined this based on the input from our clinical collaborators. This is a common
approach in the literature for patient prioritization (see, for example, Naylor 1991).
Our goal is to guarantee that all patients are offered at least one surgery day within
their MWTT in the planning solution. It is worth noting that if a patient doesn’t seize
the offered surgery date (for any reason), we can offer them the next available surgery
date but we cannot guarantee that the alternative date is within their MWTT. Table
4.1 summarizes the patient priority type for each combination of indication, referral
type, and geographical zone. Table 4.2 provides the MWTT for each priority type in
business days. For example, a colon cancer patient who has traveled from overseas and
is referred to CRS internally is considered as priority 1. Consequently, we would like to
offer a clinic and a surgery appointment to him/her within 3 business days. Note that
rectal cancer patients are considered as type 5 because of the long required duration
between clinic appointment and surgery due to chemotherapy. Also, throughout this
paper, we only focus on business days since CRS is off during the weekends.
4.4.3 Logistic Regression
In this section, we develop a logistic regression model (also known as the logit
model) in order to predict the probability of a new clinic appointment order will
result in a surgery. We refer to this as the “probability of surgery” from now on. In
the logit model the log odds of the outcome (response variable) is modeled as a linear
combination of the independent variables (covariates). The patient’s indication, age,
and referral type are the covariates of the logit model. Eq. 4.1 presents the logit
model in which y is the logit transform of the probability of surgery and I(x) is an
indicator function. For example I(Crohn′s) is equal to 1 if the patient’s indication is
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Table 4.1: Patient priority type for different combinations of patient indication, re-
ferral type, and zone. Smaller priority level numbers are associated with
more urgent patients. Priorities 1, 2, 3, and 4 are assigned to patients
who might need a surgery following their clinic visit to CRS. Priority 5 is
assigned to patients who only need a clinic visit for follow-up/consult.
Table 4.2: Maximum wait time target to surgery for different patient priority types.
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Crohn’s disease and 0 otherwise.
y = 0.72279 ∗ I(crohn′s)− 0.45483 ∗ I(neoplasi)− 0.69236 ∗ I(STC)− 0.65543 ∗ I(other)
− 0.00937 ∗ age+ 0.53546 ∗ I(internal referral) + 0.39429 ∗ I(external referral).
(4.1)
Therefore, the probability of surgery can be obtained via
p =
ey
1 + ey
. (4.2)
4.4.4 Scheduling Policies/Protocols
In this subsection, we introduce 6 scheduling policies considered in our analysis.
We evaluate the performance of these policies in terms of average OR overtime per
day in the Section 4.5 using a 2-stage stochastic and dynamic simulation model.
In order to define the policies, the following terminology is needed:
• Earliest Feasible Clinic (EFC) is the earliest day we can schedule a clinic visit
appointment for the patient. For a clinic appointment request that is received
on day t, if it is an internally referred patient (meaning that the patient is
physically at the Mayo Clinic), we assume EFC is the same day (i.e., day t).
For external referrals, we assume EFC is 5 business days from the day the
appointment request is received (i.e., t + 5) to give the patients at least one
week to make travel arrangements to Mayo. In other words,
EFC = t+ 0× I(internal referral) + 5× I(external referral). (4.3)
• Clinic to Surgery Gap (CSG) is an arbitrary number that corresponds to the
required number of days between the patient’s clinic and surgery appointments.
This number depends on the patient’s priority type and the probability of
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surgery obtained from the logistic regression model. Recall that (1) we ten-
tatively reserve a surgery date for all patients before we know if the patient will
require a surgery, and (2) the decision of whether or not to perform a surgery is
made during the patient’s clinic visit. To avoid the waste of OR time in cases
where the patient doesn’t end up pursuing a surgery, we space out the clinic and
surgery appointments for patients with low probability of surgery. In general,
the lower the probability of surgery is, the larger the CSG should be. This gives
us some time to assign the OR time of a canceled tentatively booked surgery
to a new patient and prevent the OR time from getting wasted.
• Earliest Feasible Surgery (EFS) is the earliest day we can schedule the surgery
for the patient. Per definition, EFS = EFC + CSG for all patients.
The above definitions and approach represent a new paradigm for setting appoint-
ments in advance while being sensitive to waiting times for service. The concept is
intuitive and relatively simple to implement. There are, however, details that must be
resolved to render the approach effective. Next, we are going to define the scheduling
policies. These policies first find a tentative surgery day and a surgeon for the patient;
then, they schedule a clinic appointment with the same surgeon prior to the tentative
surgery day. Both are done at the time the order for clinic appointment is received
by CRS. We first describe how each policy finds a tentative surgery day. Then, we
elaborate on how the clinic appointment day is determined. Recall that the current
scheduling policy of CRS was defined in Section 4.2.
4.4.4.1 Finding a tentative surgery day
Policy A: Assign the patient to the surgeon with the earliest OR availability
in the interval [EFS,MWTT ] starting from EFS and moving forward in time. If
there is no availability in this interval, assign her to the surgeon-day with the most
remaining surgical availability in this interval and use OR overtime.
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Policy B: If the patient is of priority 1, follow the rules of Policy A. If the patient
is of priority 2, 3, or 4, assign her to a surgeon with sufficient OR availability in the
interval [EFS,MWTT ] starting with day MWTT and moving backward in time. If
there is no availability in this interval, assign her to the surgeon-day with the most
remaining surgical availability in this interval and use OR overtime. This is similar
to the policy derived in Patrick et al. (2008).
Policy C: If the patient is of priority 1, follow the rules of Policy A. If the patient is
of priority 2, 3, or 4, sort the days in the interval [EFS,MWTT ] in descending order
of aggregated surgical availability. Assign the patient to a surgeon with sufficient OR
availability starting with the first day on this list (i.e., the least busy day) and moving
down the list. If there is no availability in this interval, assign her to the surgeon-day
with the most remaining surgical availability in this interval and use OR overtime.
Policy D: If the patient is of priority 1, follow the rules of Policy A. If the patient is of
priority 2, 3, or 4, follow the procedure of Policy C in order to find a tentative surgery
date for the patient using regular OR time. If there is no availability in the interval
[EFS,MWTT ], calculate the “expected” surgical workload of each surgeon-day on
this interval. Then, assign the patient to the surgeon-day with the least expected
surgical workload (i.e., the most expected surgical availability) and use OR overtime.
The expected surgical workload of surgeon i on day t is calculated via
E[W (i, t)] =
∑
s∈S(i,t)
psE[Ds], (4.4)
where E[W (i, t)] is the expected workload of surgeon i on day t, S(i, t) is the set of
surgeries assigned to surgeon i on day t, ps is the probability of surgery s (obtained
via the logit model), and E[Ds] is the expected duration of surgery s. The idea
behind policy D is to take the uncertainty of the tentatively booked surgeries into
consideration when we select a surgeon-day for using OR overtime. For example,
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consider days t1 and t2 as the candidate surgery days for a new order with expected
surgery duration of 3 hours. Further, assume that we have only one surgeon with
surgical capacity of 8 hours per day. Day t1 includes two tentatively booked surgeries
of length 3 and 4 hours with probabilities of surgery of 0.3 and 0.2, respectively. Day
t2 includes two other tentatively booked surgeries of length 2 and 4 hours with 0.8
probability of surgery for both. Under policy C, day t2 is selected for the new order
because 2+4 < 3+4. However, under Policy D, day t1 is selected because the effective
surgical workload of the surgeon on day t1 (0.3 ∗ 3 + 0.2 ∗ 4 = 1.7 hrs) is less than
that of day t2 (0.8 ∗ 2 + 0.8 ∗ 4 = 4.8 hrs).
Policy E: If the patient is of priority 1, follow the rules of Policy A. If the patient
is of priority 2, 3, or 4 (i.e., p ∈ {2, 3, 4}), follow the same procedure as Policy C but
limit the search for a surgery day to the interval [max(EFS,MWTTp−1),MWTTp].
In here, MWTTp is the MWTT of the patient under consideration whose priority is
p and MWTTp−1 is the MWTT of priority p− 1 patients.
Policy F: If the patient is of priority 1, follow the rules of Policy A. If the patient is
of priority 2, 3, or 4 (i.e., p ∈ {2, 3, 4}), follow the same procedure as Policy D but
limit the search for a surgery day to the interval [max(EFS,MWTTp−1),MWTTp].
4.4.4.2 Finding a clinic appointment day
While the 6 scheduling policies differ in how they find a tentative surgery day
for the patient, they all follow the same procedure in order to determine the clinic
appointment day. If the patient is internally referred to CRS (i.e., he/she is physically
located at the Mayo Clinic) on day t, the policies book a clinic appointment with the
same surgeon with whom the tentative surgery is booked either on the same day or
the following day (i.e., either on day t or t+ 1) depending on which day is a clinical
day for the corresponding surgeon. However, if the order is an external referral (i.e.,
the patient is not physically located at the Mayo Clinic), the clinic appointment is
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scheduled CSG days prior to the tentative surgery day. For example, suppose the
tentative surgery day is set to day t+ 10 and CSG = 3 days. If the patient is already
at Mayo (i.e., internal referral) we can offer a clinic appointment as soon as possible to
remove the uncertainty regarding the surgery decision; hence, the clinic appointment
is scheduled with the same surgeon on day t + 1. If the patient is not physically at
Mayo (i.e., external referral) the clinic appointment is scheduled on t+ 7, which gives
the patient some time to make travel plans. Mathematically, we can obtain the clinic
appointment day via Eq. 4.5,
clinic app. day = (EFC + mod(tent. surgery day − EFC + 1, 2))× I(internal referral)
+ (tent. surgery day − CSG)× I(external referral), (4.5)
in which mod(x, 2) returns the remainder after division of x by 2.
4.4.5 Performance Criteria/Penalty Function
In order to evaluate and compare the scheduling policies, we define a piecewise-
linear function that penalizes OR overtime. Per recommendation of our clinical col-
laborators, we consider 1 hour prior to and past 5 pm (i.e., 4 pm to 6 pm) as the
sweet spot for ending the surgeon’s day. Hence, we assign no penalty to the first 60
minutes of overtime for each surgeon. After that, a linear penalty is considered. Sup-
pose C(i, t) and W (i, t) are the surgical capacity and the actual/effective workload of
surgeon i on day t, respectively. The penalty of day t for surgeon i is obtained via
f(i, t) = (W (i, t)− C(i, t)− 60)+, (4.6)
in which x+ = max{x, 0}. It is worth noting that OR overtime happens because of
(1) lack of accuracy in estimating the surgery duration, and (2) intentionally “over-
booking” on some days to maintain the access delay service level.
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4.5 Simulation Optimization Results
We begin this section by describing our 2-stage stochastic and dynamic discrete-
event simulation and continue by presenting numerical results. In the first stage of
our simulation model, we evaluate the performance of the 6 policies described in
Subsection 4.4.4 for different order arrival rates under a fixed assumption on clinic to
surgery gap (CSG). In the second stage, we fine-tune the winning policy of stage 1
by investigating the CSG function. We will call the fine-tuned version of the winning
policy “the optimal policy” and further evaluate its performance.
We created a stochastic discrete-event simulation model of the CRS appointment
system in MATLAB. It is assumed that requests/orders for clinic appointment arrive
to CRS according to a Poisson process with rate λ. We consider online scheduling
of orders. In other words, orders arrive one by one and get scheduled in the order
they arrive. Each order is generated as a random sample from our large dataset.
When a new order arrives (1) the patient’s priority level is determined based on
Table 4.1, (2) the maximum wait time target (MWTT) is determined based on Table
4.2, (3) the probability of surgery is calculated via Eq. 4.2, (4) the earliest feasible
clinic (EFC) appointment day is determined via Eq. 4.3, (5) the clinic to surgery
gap (CSG) is considered as 1 day if the priority level is 1 and 3 days otherwise
(this will be further studied in the second stage of our simulation model), (6) a
tentative surgery appointment is scheduled following the rules of the policy under
consideration (see Section 4.4.4.1 for more details), and (7) a clinic appointment is
scheduled according to the approach described in Section 4.4.4.2. At the end of an
arbitrary day t, the simulation model either confirms or cancels the tentatively booked
surgery appointments for patients whose clinic appointment was scheduled on day t.
This is done by generating a random uniformly distributed number between 0 and
1 and comparing it against the patient’s probability of surgery. Note that to better
reflect practice we are taking a conservative approach and assume that the tentative
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surgery appointments that are canceled throughout the day are realized at the end
of the day (therefore, they cannot be rebooked until the following day).
Each replication of simulation is run for 350 days. Since we start with an empty
system (i.e., all surgeons have full availability at the start of the simulation) we allow
100 days of warmup and use the data of days 101 to 350 (roughly one year since
these are business days) to compare the policies. Note that orders may be scheduled
beyond day 350; therefore, there is no end-of-horizon effect.
4.5.1 Simulation stage 1: comparing policies to find the winning policy
In the first stage of our stochastic simulation approach, we compare the scheduling
policies for different rates of Poisson arrival process. We use the penalty function of
Eq. 4.6 to calculate a penalty score for each policy. Mayo CRS performs about 200
surgeries per month. This corresponds to a rate of about 30 orders per day (remember
that not every order results in a surgery). In this paper, we investigate arrival rates
from 20 to 40 orders per day in increments of 2. We performed 200 replications
of the simulation and calculated the daily overtime penalty of each replication (i.e.,
1
250
350∑
t=101
8∑
i=1
f(i, t), where f(i, t) is given in Eq. 4.6), then took the average of these
daily overtime penalties. Table 4.3 summarizes the results. As can be seen in Table
4.3, Policy D performs better than the other scheduling policies and results in smaller
average overtime penalty per day. We also simulated the current scheduling policy
described in Section 4.2. It is worth noting that all of the 6 scheduling policies, which
tentatively book a surgery day at the same time the clinic appointment day is set,
significantly outperform the current policy that waits until the clinic visit to book
the surgery. Figure 4.2 portrays the variation of overtime penalty per day among
simulation runs using jitter and box plots. Figure 4.3 depicts the average overtime
penalty per day for Policy D and the current policy for different rates of the arrival
process. At the rate of 30 orders per day (about 200 surgeries per month) which
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Table 4.3: Average overtime penalty per day for the 6 scheduling policies and the
policy of the current practice under different arrival rates. Policy D out-
performs the rest for every rate in the range.
corresponds to the present business of Mayo CRS, Policy D performs 43% better
than the current scheduling policy.
4.5.2 Simulation stage 2: fine-tuning the winning policy
Having found strong evidence that Policy D is the best policy among the 6 policies
we investigated, we next fine-tune Policy D by evaluating its performance under
different clinic to surgery gaps (CSGs). Recall that in the first stage of the simulation
we assumed a CSG of 1 day for priority 1 and 3 days for other priority type patients.
Now, we assume that the CSG can be 1, 3, or 5 days, and set the value based on the
particular patient’s probability of surgery, which is obtained from the logit model.
The lower the probability of surgery is, the longer the gap between clinic and surgery
appointments should be. This is because we are tentatively booking a surgery day
for all patients before knowing whether the patient will actually need a surgery. If
during the clinic visit it is deemed that the patient does not need a surgery, we will
have CSG− 1 days to assign that OR time to another patient. Note that (1) we do
not consider CSGs of 2 and 4 days because if the tentative surgery is scheduled on
day t, the surgeon will not be in the clinic on days t− 2 and t− 4 to see the patient;
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Figure 4.2: The overtime penalty per day of different scheduling policies and the
current policy. All six policies outperform the current policy. Policy D
performs the best, followed closely by Policy F.
and (2) the CSG cannot be 5 days for priority 1 patients because the MWTT for
them is 3 days. Therefore, we consider the following CSG function:
CSG =
 1× I(p ≥ α) + 3× I(p < α) if priority = 11× I(p ≥ β) + 3× I(γ ≤ p < β) + 5× I(p < γ) if priority ∈ {2, 3, 4}
(4.7)
in which p is the patient’s probability of surgery and α, β, and γ are probability
thresholds that determine which indicator functions are equal to 1. In this subsection,
our goal is to find a good combination of α, β, and γ. We assume CSG is 3 days for
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Figure 4.3: The average overtime penalty per day of Policy D and the current policy
for different rates of the arrival process. The Policy D results in 43% less
overtime penalty compared with the current scheduling policy of CRS at
200 surgeries per month.
all priority 2, 3, and 4 patients (i.e., β = 1 and γ = 0) and evaluate Policy D under
different values of α. For each value we calculate the average overtime penalty per
day based on 200 replications of the simulation model. Table 4.4 provides the results.
It reveals that a threshold level of α = 0.4 results in slightly better performance of
this policy. Now that we have approximated the optimum value of α, we evaluate
the performance of Policy D under different values of β and γ fixing α at 0.4. Table
4.5 presents the results. As can be seen in the table, Policy D performs better with
threshold levels of β = 0.8 and γ = 0.5. From now on, we call the fine-tuned version
of Policy D “the optimal policy” or “Policy D*”.
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Table 4.4: Average overtime penalty per day under Policy D for different values of α
when β = 1 and γ = 0. The threshold level of α = 0.4 results in slightly
better performance.
4.5.3 The optimal policy (Policy D*)
Now that we found a good combination of the probability thresholds in the CSG
function proposed in Eq. 4.7, below we summarize the steps of our methodological
framework for coordinating clinic and surgery appointments to meet access delay
service levels using the optimal policy (policy D*). For each new clinic appointment
order/request take the following procedure:
Step 1: determine the patient’s priority level, MWTT, probability of yielding a
surgery, and EFC using Table 4.1, Table 4.2, and Eq. 4.2, and Eq. 4.3, respectively.
Step 2: Use Eq. 4.7 to calculate the CSG with α = 0.4, β = 0.8 and γ = 0.5.
Step 3: Perform the following in order to schedule a tentative surgery day:
• If the patient is of priority 1, assign her to the surgeon with the earliest OR avail-
ability in the interval [EFS,MWTT ] starting from EFS and moving forward
in time. If there is no availability in this interval, assign her to the surgeon-day
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Table 4.5: Average overtime penalty per day under Policy D for different values of β
and γ when α = 0.4. The Policy D performs better with threshold levels
of β = 0.8 and γ = 0.5.
with the most remaining surgical availability (or the least amount of overtime)
in this interval and use OR overtime.
• If the patient is of priority 2, 3, or 4, sort the days in the interval [EFS,MWTT ]
in descending order of aggregated surgical availability. Assign the patient to a
surgeon with sufficient OR availability for the expected surgery length of the
case starting with the first day on this list (i.e., the least busy day) and moving
down the list. If there is no availability in the interval [EFS,MWTT ], calculate
the expected surgical workload of each surgeon-day on this interval using Eq.
4.4. Then, assign the patient to the surgeon-day with the least expected surgical
workload (i.e., the most expected surgical availability) and use OR overtime.
Step 4: Use Eq. 4.5 in order to schedule a clinic appointment day for the patient
with the same surgeon.
Step 5: During the clinic appointment, if the surgeon and the patient decide to
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pursue a surgery, offer the tentatively booked surgery day (this is guaranteed to be
within their MWTT). If that day does not work for the patient, go to step 6.
Step 6: Offer the surgeon’s next surgical availability (this is not guaranteed to be
within the patient’s MWTT). If that day does not work for them, repeat step 6 until
a surgery day is found.
4.5.4 The optimal vs. the current policy
In this subsection, we compare the average overtime penalty per day of Policy D*
with that of Policy D and the current policy (i.e., the scheduling policy in current
practice) using the previous simulation performance analysis approach. Figure 4.4
depicts the results. It can be seen in Figure 4.4 that at arrival rate of 30 orders per
day (about 200 surgeries per month), Policy D* performs 17% better than Policy D
and 52% better that the current policy. Figure 4.5 shows the box plots of the three
policies at different arrival rates to depict the variation of overtime penalty per day
among simulation runs. Note that in this figure the horizontal axis is a factorial
vector of arrival rates with 11 levels (from 20 to 40 in increments of 2) and not a
continuous scale.
4.6 Conclusions
Patients are referred to the colorectal surgery (CRS) department at the Mayo
Clinic either internally or externally. They first see a surgeon in the clinic, and
usually the clinic visit is followed by a surgery. Recently, CRS has been experiencing
a rapid increase in the waiting time for the next available surgery day they can offer
to the patients. The increased wait times can negatively impact patient safety and
health outcomes.
In this paper, we presented a 2-stage stochastic and dynamic discrete-event simulation
model that finds (1) a tentative surgery day with a surgeon in CRS, and (2) a clinic
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Figure 4.4: The average overtime penalty per day of Policies D*, D, and the current
policy for different rates of the arrival process. The optimal policy (Pol-
icy D*) results in 52% less overtime penalty compared with the current
scheduling policy of CRS at 200 surgeries per month.
appointment day with the same surgeon, for all new patents referred to CRS such that
(1) all patients are offered at least one clinic and surgery day prior to their maximum
wait time target (MWTT), and (2) OR overtime is minimized. To evaluate scheduling
policies we developed a simulation model based on historical patient data from Mayo
CRS. In the first stage of our approach, we investigated 6 different scheduling policies
that all outperform the current scheduling policy and found the best/winning policy.
In the second stage, the winning policy was fine-tuned through the investigation of
different variations of the clinic to surgery gap. The fine-tuned version of the winning
policy (i.e., the optimal policy) was compared against the current practice. Numerical
results confirm that the optimal policy performs 52% better that the current policy
in terms of the average overtime per day.
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Figure 4.5: The box plots of overtime penalty per day of Policies D*, D, and the
current policy for different rates of the arrival process. Policy D* clearly
performs the best.
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CHAPTER V
Conclusions and Future Research
This dissertation has focused on developing new stochastic control and optimiza-
tion models to improve medical decision making and healthcare operations with the
objective of improving health outcomes and cost containment. These objectives were
achieved through better personalizing both the medical care itself and the operational
aspects of the delivery of care in the work on medical decision making for chronic dis-
eases, which focused on glaucoma. In other chapters, the operational/logistical aspect
of care delivery was addressed through improving patient safety by reducing medical
errors and providing timely access to care to the right patients based on the urgency
needs of different types of patients.
Chapter II contributes to the medical decision making literature by developing a dy-
namic, personalized modeling paradigm for simultaneous monitoring and control of
chronic diseases. Unlike previous research that solves the monitoring and treatment
control problems in isolation, we provide a joint optimal solution to both problems in
an integrated model. Our model incorporates each patient’s past and present read-
ings in a feedback-driven control model to provide the answer to two critical questions
facing clinicians: (1) when to schedule office visits and which suite of test to perform
to monitor disease progression (exploration); and (2) what levels of key disease risk
factors should be targeted to slow the rate of disease progression (exploitation). For
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glaucoma, a progressive eye disease that can lead to blindness, our model determines
the best time to measure patient’s intraocular pressure (IOP) and/or take a visual
field (VF) test. Additionally, it provides a patient-specific target IOP to slow glau-
coma progression. Since IOP is the only modifiable glaucoma risk factor, having such
information will help the doctor select the appropriate treatment plan for the patient.
Kalman filtering methodology is built into our modeling framework to extract noise
from the raw measurements and to optimally estimate the disease state in each time
period based on imperfect observations. This is a key to accurately identify genuine
disease progression from testing artifact since both IOP and VF tests are associated
with significant noise. Further, the algorithm can perform at different aggressiveness
levels (low, moderate, and high-aggressiveness) based on individual patient charac-
teristics (e.g. a 40-year-old patient with advanced disease vs. a 90-year-old patient
with mild disease).
Capturing the complex patient disease dynamics requires incorporating several phys-
iological indicators into the state vector. These state elements are best modeled
with continuous state space model, reflecting continuous test measurements which
have been found to have approximately Normal additive noise. A vector state space
model of patient disease progression based on the linear quadratic Gaussian (LQG)
dynamic control framework allowed us to create a data-driven model that separates
process noise from measurement noise, and allows for incomplete/imperfect state ob-
servations. Our models can be described as possessing “measurement subsystems
control,” because the optimization and control must dynamically decide which mea-
surements (tests of the patient) to take at each instant of time, thereby controlling
the times at which tests are taken. Furthermore, the need to model testing process
noise makes approximate dynamic programming (ADP), partially observable Markov
decision processes (POMDP), and other approaches common in the medical decision
making literature less effective in developing tractable solution methods for monitor-
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ing and treatment control for chronic diseases. By developing a multivariate continu-
ous state space model of disease progression and modeling the state transition and the
testing processes as first order vector difference equations with multivariate Gaussian
random noises, we surmount the computational hurdles of these other methods.
Chapter II also contributes to the literature on linear quadratic Gaussian (LQG) state
space systems modeling and the theory of optimal control of measurement adaptive
systems by introducing a new objective that minimizes the relative change in state
(i.e., disease progression) rather than the traditional objective of simply minimizing
the cost of being in each state. This new objective is important for our application
since the goal is to prevent the patient from getting worse (in the setting of progress-
ing diseases which are irreversible but can be slowed or arrested). Further, we proved
an important result that the classical two-way separation of optimal estimation and
control extends to this new objective of relative system state change. This is a funda-
mental finding upon which solution tractability depends. Leveraging this result, we
were able to show that the optimal treatment control action at each time point is a
linear function of filtered state mean, while the function itself (i.e., the control law)
can be calculated offline. Moreover, we showed that the optimal monitoring schedule
can be obtained by solving a recursive value function of filtered and smoothed covari-
ance matrices of the state via branch and bound dynamic programming.
To demonstrate the effectiveness of our approach, we harnessed two 10+ year ran-
domized clinical trials to parametrize and validate our model: the Collaborative Ini-
tial Glaucoma Treatment Study (CIGTS) and the Advanced Glaucoma Intervention
Study (AGIS). Our numerical results demonstrated that our model not only results
in patients with better vision quality over the treatment horizon, but also achieves
significantly slower glaucoma progression rate, which means patients keep their sight
longer.
Given the power of our approach, we expect that our new medical decision making
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formulation and solution approach will be confirmed by future work from other re-
searchers, and that a new research area for the healthcare operations research and
medical community will flourish to advance quality of care and quality of life for pa-
tients with chronic diseases.
While our modeling framework has shown great potential in improving the monitoring
and control of chronic disease patients with glaucoma, it comes with a few limitations
and areas for improvement. First, we only considered the IOP and VF tests in devel-
oping a monitoring schedule for the patient, whereas in practice there are additional
tests that can also be used to monitor glaucomatous progression. For instance, op-
tical coherence tomography (OCT) is a non-invasive imaging test that measures the
thickness of retinal nerve fiber layer (RNFL) (see Schuman et al. (2004)). This newer
testing modality was not commercially available at the time of the CIGTS and AGIS
clinical trials on which our analysis is based. Fortunately, the decision framework we
have developed is scalable and can easily accommodate quantitative data of tests such
as OCT. Should newer modalities for quantitatively assessing the status of a patient’s
glaucoma arise, data from such modalities can be incorporated into the model as well.
In the future, we hope to acquire access to other data sources which contain OCT
data and expand our state vector to accommodate data from this testing modality.
Second, the focus of our work is on patients who already have glaucoma (mild, moder-
ate, or advance glaucoma). Our model provides scheduling regimes and IOP reduction
suggestions to optimally monitor and control the progression of glaucoma. However,
some patients have elevated eye pressures (i.e., ocular hypertension) with no signs of
glaucoma. These patients are usually considered as “glaucoma suspects” and are at
risk of developing glaucoma. Future research can enhance the model to help forecast
which of these patients will go on to develop glaucoma and how often these patients
should be monitored to see if they develop glaucoma.
Third, we used 6-month spaced time intervals because CIGTS and AGIS datasets
124
contain readings of patient’s IOP and VF every six months. One can leverage the
same modeling framework for data that is collected more or less frequently (e.g.,
monthly or every 3 months) without loss of generality. However, expanding our al-
gorithm to automatically handle unequally spaced data is another potential path for
future research.
Moreover, it is important to emphasize that our model does not suggest a specific
medicine, laser therapy, or surgery. Rather, it provides a patient specific target IOP
that helps guide the doctor in selecting an appropriate treatment plan. Though one
might try to model how each glaucoma intervention affects the disease progression
dynamics, we feel that it is best to leave it to the clinician to employ his/her expe-
rience and expertise to decide what therapeutic interventions are most likely able to
achieve the target IOP suggested by our model.
Finally, future research can focus on further studying the model cost parameters. In
this research, we relied on expert opinion and developed a set of cost parameters for
each aggressiveness policy that performed on our extant data. Future research, how-
ever, can try to develop algorithms to optimize the balance between the cost of losing
vision over time from glaucoma, cost of purchasing medications/undergoing surgery,
cost of office visit and diagnostic testing, anxiety and stress of undergoing glaucoma
tests, and side effects and complications of medical and surgical therapy to lower IOP
further.
In Chapter III we aimed to reduce medical errors and therefore, improve patient
safety, by designing a new work shift schedules for residents and fellows to mini-
mize the number of error-prone patient handoffs. Patient handoffs are among the
primary sources of medical errors in inpatient hospital care due to communication
breakdowns. Several studies have focused on the fidelity of handoffs and provided
recommendations and protocols to improve the communication aspects of handoffs.
In this chapter, we contributed to the patient handoff literature by providing an
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integer programming-based approach to design physician’s work shift schedule in a
patient-centered manner that minimizes the number of patient handoffs while respect-
ing duty-hour standards. The ACGME rules allow shifts up to 24 hours. Based on
several discussions with our medical collaborators at the Mayo Clinic, we found that
limiting the shift length to 16-hours provided a reasonable tradeoff between medical
errors due to physician fatigue and medical errors due to communication breakdowns
as a result of more frequent patient handoffs. Therefore, we proposed to increase the
current shift length from 12 to 16 hours, which reduces the number of handoffs while
avoiding high fatigue-inducing shifts.
Using historical data from a medical ICU at the Mayo Clinic, we demonstrated that
the computer-generated schedule with 16-hour shifts results in 23% reduction in the
number of patient handoffs. It is worth noting that the proposed schedule satisfies all
of the required scheduling rules, provide the required coverage, and maintains physi-
cian quality of life by satisfying a set of desired livability constraints in addition to
the required constraints. Further, we added fairness constraints to ensure that all the
physicians get almost the same number of hours on duty, night shifts, and days off.
There are, however, several directions for future research in this line. First, it is not
currently known how much the extra weariness due to longer shifts contributes to
fatigue-related medical errors. If physician fatigue and its effect on medical errors
can be quantified in a systematic way, it will help in scientifically evaluating sched-
ules that minimize the number of patient handoffs. Second, the connection between
ICU rounding time and patient census pattern could be further investigated. In this
study, we included a required constraint to keep bedside rounds at the current time
to avoid the complex effect of rounding time on the patient discharge process, which
directly influences ICU patient census.
Chapter IV presented novel ideas on coordinating clinic and surgery appointment
scheduling with the objective of improving timeliness of access to surgery. In collab-
126
oration with colorectal surgery (CRS) at the Mayo Clinic, we showed how patient
information can be used to proactively schedule a tentative surgery day for all pa-
tients at the same time that we schedule a clinic appointment for them. Patients are
classified into different types based on their indication, geographical zone, and referral
source. Each type is associated with a maximum wait time target (MWTT) that is
determined based on expert opinion from the leadership of Mayo Clinic. This is the
maximum time each patient’s surgery can be safely delayed. Further, we developed
a logit model to calculate the probability that an arriving patient of any type will
yield a surgery in CRS. Surgery duration is also estimated for all incoming patient
types based on historical patient data. We schedule a clinic appointment day and a
tentative surgery day for all patients by their MWTT to guarantee that at least one
surgery day is offered to all patients without jeopardizing their health status due to
access delay. Overtime is used if it is the only way to achieve the MWTT access.
However, the clinic appointment days and the tentative surgery days are determined
by algorithms that carefully space them out to ensure that when the tentative surgery
bookings are not needed (i.e., get canceled) they can be assigned to other patients.
This tradeoff of utilization/overtime versus waiting time is a difficult one at the core
of this chapter.
To solve this problem, we developed a 2-stage stochastic and dynamic discrete event
simulation model to compare the performance of 6 heuristic scheduling policies. It is
worth noting that all 6 policies significantly outperform the current scheduling policy.
The current policy sets a surgery day for the patient at the time of his/her clinic visit.
In the first stage of the simulation model, we found the policy that works best among
the 6 policies (which we call the winning policy). In the second stage, we fine-tuned
the winning policy by optimizing the rules that determine the distance/gap between
clinic and surgery days. All of the policies will achieve the MWTT goals, using over-
time when needed. Numerical results confirm that the optimal policy performs 52%
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better that the current policy in terms of the average overtime per day. While the
proof of concept study is given for Mayo CRS, this methodology can be applied to any
specialty care unit that provides clinic and surgery appointments. Future research
can study the effect of MWTTs on the optimal policy and/or develop a modeling
framework to dynamically update the MWTTs based on the current workload of the
surgeons. Moreover, in this research we assumed that (1) all patients must get at least
one clinic and surgery day by their MWTT, and (2) overtime will be used as needed
to accommodate the surge capacity. One can relax this assumption by trying to bal-
ance the tradeoff between using overtime and missing the MWTTs. In this case, the
system should be penalized more for missing the MWTT of higher priority patients.
Lastly, while we studied the performance of 6 carefully chosen scheduling policies, it
is possible to investigate additional heuristic scheduling policies, in particular those
that belong to the category of threshold policies. In this type of policies, a certain
percentage of capacity is reserved for each priority type patients. The threshold limit
of each day may be relaxed as we get close to the day to avoid the risk of ending
up with unused clinic and operating room time. All of the research presented in this
dissertation has been done in close collaboration with several medical collaborators
from cutting-edge healthcare organizations (i.e., University of Michigan Health Sys-
tem and the Mayo Clinic) to identify real-world problems, obtain relevant datasets,
and ensure practical significance. Combining the ideas and methods developed in this
dissertation will result in a step toward bending the cost curve of healthcare spending
and can contribute to a positive impact on health outcomes and improve the quality
of life for many people.
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